Reported covered position: Legislative Director, Rep. H. Morgan Griffith
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION · Firm: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION
H.R. 1940, the Tanning Tax Repeal Act of 2025; H.R. 1, the One Big Beautiful Bill Act
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION · Firm: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION via AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION
2026 · third_quarter · Q3
H.R. 1968, the Full-Year Continuing Appropriations and Extensions Act, 2025
H.R. 1940, the Tanning Tax Repeal Act of 2025; H.R. 1, the One Big Beautiful Bill Act
Source: Senate LDA
H.R. 1940, the Tanning Tax Repeal Act of 2025; H.R. 1, the One Big Beautiful Bill Act
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION · Firm: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION
H.R. 879/S. 1640, the Medicare Patient Access and Practice Stabilization Act of 2025; H.R. 1, the One Big Beautiful Bill Act; H.R. 3164/S. 2426, the Ensuring Community Access to Pharmacist Services Act; Draft legislation to amend title XVIII of the Social Security Act to modify the conversion factor updates applicable to physicians' services under the Medicare program; Implementation of Centers for Medicare & Medicaid Services. (2025). Medicare and Medicaid Programs; CY 2026 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program. Federal Register, 88, 90 FR 49266-50481; H.R. 6160, the Strengthening Medicare for Patients and Providers Act; H.R. 8163, the Provider Reimbursement Stability Act; H.R. 7520, the Efficiency Adjustment Delay Act; H.R. 8622, the Medicare Physician Data-driven Performance Payment System Act of 2026
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION · Firm: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION
H.R. 1940, the Tanning Tax Repeal Act of 2025; H.R. 1, the One Big Beautiful Bill Act
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION · Firm: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION
H.R. 879/S. 1640, the Medicare Patient Access and Practice Stabilization Act of 2025; H.R. 1, the One Big Beautiful Bill Act; H.R. 3164/S. 2426, the Ensuring Community Access to Pharmacist Services Act; Draft legislation to amend title XVIII of the Social Security Act to modify the conversion factor updates applicable to physicians' services under the Medicare program; Implementation of Centers for Medicare & Medicaid Services. (2025). Medicare and Medicaid Programs; CY 2026 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program. Federal Register, 88, 90 FR 49266-50481; H.R. 6160, the Strengthening Medicare for Patients and Providers Act; H.R. 8163, the Provider Reimbursement Stability Act; H.R. 7520, the Efficiency Adjustment Delay Act; H.R. 8622, the Medicare Physician Data-driven Performance Payment System Act of 2026 H.R.9693, Patients First Act of 2026 H.R.4331, Access to Claims Data Act Proposed CY 2027 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION · Firm: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION
H.R. 879/S. 1640, the Medicare Patient Access and Practice Stabilization Act of 2025; H.R. 1, the One Big Beautiful Bill Act; H.R. 3164/S. 2426, the Ensuring Community Access to Pharmacist Services Act; Draft legislation to amend title XVIII of the Social Security Act to modify the conversion factor updates applicable to physicians' services under the Medicare program; Implementation of Centers for Medicare & Medicaid Services. (2025). Medicare and Medicaid Programs; CY 2026 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program. Federal Register, 88, 90 FR 49266-50481; H.R. 6160, the Strengthening Medicare for Patients and Providers Act; H.R. 8163, the Provider Reimbursement Stability Act
Tanning Tax Repeal Act of 2025
Client: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION · Firm: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION
H.R. 1940, the Tanning Tax Repeal Act of 2025; H.R. 1, the One Big Beautiful Bill Act
Tanning Tax Repeal Act of 2025
Client: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION · Firm: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION
H.R. 1940, the Tanning Tax Repeal Act of 2025; H.R. 1, the One Big Beautiful Bill Act
Tanning Tax Repeal Act of 2025
Client: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION · Firm: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION
H.R. 1940, the Tanning Tax Repeal Act of 2025; H.R. 1, the One Big Beautiful Bill Act
Full-Year Continuing Appropriations and Extensions Act, 2025
Client: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION · Firm: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION
H.R. 1968, the Full-Year Continuing Appropriations and Extensions Act, 2025
Full-Year Continuing Appropriations and Extensions Act, 2025
Client: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION · Firm: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION
H.R. 1968, the Full-Year Continuing Appropriations and Extensions Act, 2025
Full-Year Continuing Appropriations and Extensions Act, 2025
Client: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION · Firm: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION
H.R. 1968, the Full-Year Continuing Appropriations and Extensions Act, 2025
Ensuring Community Access to Pharmacist Services Act
Client: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION · Firm: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION
H.R. 879/S. 1640, the Medicare Patient Access and Practice Stabilization Act of 2025; H.R. 1, the One Big Beautiful Bill Act; H.R. 3164/S. 2426, the Ensuring Community Access to Pharmacist Services Act; Draft legislation to amend title XVIII of the Social Security Act to modify the conversion factor updates applicable to physicians' services under the Medicare program; Implementation of Centers for Medicare & Medicaid Services. (2025). Medicare and Medicaid Programs; CY 2026 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program. Federal Register, 88, 90 FR 49266-50481; H.R. 6160, the Strengthening Medicare for Patients and Providers Act; H.R. 8163, the Provider Reimbursement Stability Act
Ensuring Community Access to Pharmacist Services Act
Client: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION · Firm: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION
H.R. 879/S. 1640, the Medicare Patient Access and Practice Stabilization Act of 2025; H.R. 1, the One Big Beautiful Bill Act; H.R. 3164/S. 2426, the Ensuring Community Access to Pharmacist Services Act; Draft legislation to amend title XVIII of the Social Security Act to modify the conversion factor updates applicable to physicians' services under the Medicare program; Implementation of Centers for Medicare & Medicaid Services. (2025). Medicare and Medicaid Programs; CY 2026 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program. Federal Register, 88, 90 FR 49266-50481; H.R. 6160, the Strengthening Medicare for Patients and Providers Act; H.R. 8163, the Provider Reimbursement Stability Act; H.R. 7520, the Efficiency Adjustment Delay Act; H.R. 8622, the Medicare Physician Data-driven Performance Payment System Act of 2026
Ensuring Community Access to Pharmacist Services Act
Client: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION · Firm: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION
H.R. 879/S. 1640, the Medicare Patient Access and Practice Stabilization Act of 2025; H.R. 1, the One Big Beautiful Bill Act; H.R. 3164/S. 2426, the Ensuring Community Access to Pharmacist Services Act; Draft legislation to amend title XVIII of the Social Security Act to modify the conversion factor updates applicable to physicians' services under the Medicare program; Implementation of Centers for Medicare & Medicaid Services. (2025). Medicare and Medicaid Programs; CY 2026 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program. Federal Register, 88, 90 FR 49266-50481; H.R. 6160, the Strengthening Medicare for Patients and Providers Act; H.R. 8163, the Provider Reimbursement Stability Act; H.R. 7520, the Efficiency Adjustment Delay Act; H.R. 8622, the Medicare Physician Data-driven Performance Payment System Act of 2026 H.R.9693, Patients First Act of 2026 H.R.4331, Access to Claims Data Act Proposed CY 2027 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program
SAFE Sunscreen Standards Act
Client: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION · Firm: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION
H.R. 3686, the SAFE Sunscreen Standards Act; H.R. 4273/S. 2292, Over-the-Counter Monograph Drug User Fee Amendments; H.R. 5509/S. 2903, the Safe Step Act; H.R. 4002, the Patient Access to Higher Quality Health Care Act of 2025 Clinical Laboratory Improvement Amendment
SAFE Sunscreen Standards Act
Client: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION · Firm: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION
H.R. 3686, the SAFE Sunscreen Standards Act; H.R. 4273/S. 2292, Over-the-Counter Monograph Drug User Fee Amendments; H.R. 5509/S. 2903, the Safe Step Act; H.R. 4002, the Patient Access to Higher Quality Health Care Act of 2025
SAFE Sunscreen Standards Act
Client: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION · Firm: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION
H.R. 3686, the SAFE Sunscreen Standards Act; H.R. 4273/S. 2292, Over-the-Counter Monograph Drug User Fee Amendments; H.R. 5509/S. 2903, the Safe Step Act; H.R. 4002, the Patient Access to Higher Quality Health Care Act of 2025
Patient Access to Higher Quality Health Care Act of 2025
Client: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION · Firm: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION
H.R. 3686, the SAFE Sunscreen Standards Act; H.R. 4273/S. 2292, Over-the-Counter Monograph Drug User Fee Amendments; H.R. 5509/S. 2903, the Safe Step Act; H.R. 4002, the Patient Access to Higher Quality Health Care Act of 2025
Patient Access to Higher Quality Health Care Act of 2025
Client: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION · Firm: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION
H.R. 3686, the SAFE Sunscreen Standards Act; H.R. 4273/S. 2292, Over-the-Counter Monograph Drug User Fee Amendments; H.R. 5509/S. 2903, the Safe Step Act; H.R. 4002, the Patient Access to Higher Quality Health Care Act of 2025 Clinical Laboratory Improvement Amendment
Patient Access to Higher Quality Health Care Act of 2025
Client: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION · Firm: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION
H.R. 3686, the SAFE Sunscreen Standards Act; H.R. 4273/S. 2292, Over-the-Counter Monograph Drug User Fee Amendments; H.R. 5509/S. 2903, the Safe Step Act; H.R. 4002, the Patient Access to Higher Quality Health Care Act of 2025
Over-the-Counter Monograph Drug User Fee Amendments
Client: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION · Firm: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION
H.R. 3686, the SAFE Sunscreen Standards Act; H.R. 4273/S. 2292, Over-the-Counter Monograph Drug User Fee Amendments; H.R. 5509/S. 2903, the Safe Step Act; H.R. 4002, the Patient Access to Higher Quality Health Care Act of 2025
Over-the-Counter Monograph Drug User Fee Amendments
Client: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION · Firm: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION
H.R. 3686, the SAFE Sunscreen Standards Act; H.R. 4273/S. 2292, Over-the-Counter Monograph Drug User Fee Amendments; H.R. 5509/S. 2903, the Safe Step Act; H.R. 4002, the Patient Access to Higher Quality Health Care Act of 2025
Over-the-Counter Monograph Drug User Fee Amendments
Client: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION · Firm: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION
H.R. 3686, the SAFE Sunscreen Standards Act; H.R. 4273/S. 2292, Over-the-Counter Monograph Drug User Fee Amendments; H.R. 5509/S. 2903, the Safe Step Act; H.R. 4002, the Patient Access to Higher Quality Health Care Act of 2025 Clinical Laboratory Improvement Amendment
Access to Claims Data Act
Client: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION · Firm: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION
H.R. 879/S. 1640, the Medicare Patient Access and Practice Stabilization Act of 2025; H.R. 1, the One Big Beautiful Bill Act; H.R. 3164/S. 2426, the Ensuring Community Access to Pharmacist Services Act; Draft legislation to amend title XVIII of the Social Security Act to modify the conversion factor updates applicable to physicians' services under the Medicare program; Implementation of Centers for Medicare & Medicaid Services. (2025). Medicare and Medicaid Programs; CY 2026 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program. Federal Register, 88, 90 FR 49266-50481; H.R. 6160, the Strengthening Medicare for Patients and Providers Act; H.R. 8163, the Provider Reimbursement Stability Act; H.R. 7520, the Efficiency Adjustment Delay Act; H.R. 8622, the Medicare Physician Data-driven Performance Payment System Act of 2026 H.R.9693, Patients First Act of 2026 H.R.4331, Access to Claims Data Act Proposed CY 2027 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program
Safe Step Act
Client: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION · Firm: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION
H.R. 3686, the SAFE Sunscreen Standards Act; H.R. 4273/S. 2292, Over-the-Counter Monograph Drug User Fee Amendments; H.R. 5509/S. 2903, the Safe Step Act; H.R. 4002, the Patient Access to Higher Quality Health Care Act of 2025 Clinical Laboratory Improvement Amendment
Safe Step Act
Client: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION · Firm: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION
H.R. 3686, the SAFE Sunscreen Standards Act; H.R. 4273/S. 2292, Over-the-Counter Monograph Drug User Fee Amendments; H.R. 5509/S. 2903, the Safe Step Act; H.R. 4002, the Patient Access to Higher Quality Health Care Act of 2025
Safe Step Act
Client: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION · Firm: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION
H.R. 3686, the SAFE Sunscreen Standards Act; H.R. 4273/S. 2292, Over-the-Counter Monograph Drug User Fee Amendments; H.R. 5509/S. 2903, the Safe Step Act; H.R. 4002, the Patient Access to Higher Quality Health Care Act of 2025
Strengthening Medicare for Patients and Providers Act
Client: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION · Firm: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION
H.R. 879/S. 1640, the Medicare Patient Access and Practice Stabilization Act of 2025; H.R. 1, the One Big Beautiful Bill Act; H.R. 3164/S. 2426, the Ensuring Community Access to Pharmacist Services Act; Draft legislation to amend title XVIII of the Social Security Act to modify the conversion factor updates applicable to physicians' services under the Medicare program; Implementation of Centers for Medicare & Medicaid Services. (2025). Medicare and Medicaid Programs; CY 2026 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program. Federal Register, 88, 90 FR 49266-50481; H.R. 6160, the Strengthening Medicare for Patients and Providers Act; H.R. 8163, the Provider Reimbursement Stability Act; H.R. 7520, the Efficiency Adjustment Delay Act; H.R. 8622, the Medicare Physician Data-driven Performance Payment System Act of 2026 H.R.9693, Patients First Act of 2026 H.R.4331, Access to Claims Data Act Proposed CY 2027 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program
Strengthening Medicare for Patients and Providers Act
Client: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION · Firm: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION
H.R. 879/S. 1640, the Medicare Patient Access and Practice Stabilization Act of 2025; H.R. 1, the One Big Beautiful Bill Act; H.R. 3164/S. 2426, the Ensuring Community Access to Pharmacist Services Act; Draft legislation to amend title XVIII of the Social Security Act to modify the conversion factor updates applicable to physicians' services under the Medicare program; Implementation of Centers for Medicare & Medicaid Services. (2025). Medicare and Medicaid Programs; CY 2026 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program. Federal Register, 88, 90 FR 49266-50481; H.R. 6160, the Strengthening Medicare for Patients and Providers Act; H.R. 8163, the Provider Reimbursement Stability Act
Strengthening Medicare for Patients and Providers Act
Client: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION · Firm: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION
H.R. 879/S. 1640, the Medicare Patient Access and Practice Stabilization Act of 2025; H.R. 1, the One Big Beautiful Bill Act; H.R. 3164/S. 2426, the Ensuring Community Access to Pharmacist Services Act; Draft legislation to amend title XVIII of the Social Security Act to modify the conversion factor updates applicable to physicians' services under the Medicare program; Implementation of Centers for Medicare & Medicaid Services. (2025). Medicare and Medicaid Programs; CY 2026 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program. Federal Register, 88, 90 FR 49266-50481; H.R. 6160, the Strengthening Medicare for Patients and Providers Act; H.R. 8163, the Provider Reimbursement Stability Act; H.R. 7520, the Efficiency Adjustment Delay Act; H.R. 8622, the Medicare Physician Data-driven Performance Payment System Act of 2026
Efficiency Adjustment Delay Act
Client: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION · Firm: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION
H.R. 879/S. 1640, the Medicare Patient Access and Practice Stabilization Act of 2025; H.R. 1, the One Big Beautiful Bill Act; H.R. 3164/S. 2426, the Ensuring Community Access to Pharmacist Services Act; Draft legislation to amend title XVIII of the Social Security Act to modify the conversion factor updates applicable to physicians' services under the Medicare program; Implementation of Centers for Medicare & Medicaid Services. (2025). Medicare and Medicaid Programs; CY 2026 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program. Federal Register, 88, 90 FR 49266-50481; H.R. 6160, the Strengthening Medicare for Patients and Providers Act; H.R. 8163, the Provider Reimbursement Stability Act; H.R. 7520, the Efficiency Adjustment Delay Act; H.R. 8622, the Medicare Physician Data-driven Performance Payment System Act of 2026
Efficiency Adjustment Delay Act
Client: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION · Firm: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION
H.R. 879/S. 1640, the Medicare Patient Access and Practice Stabilization Act of 2025; H.R. 1, the One Big Beautiful Bill Act; H.R. 3164/S. 2426, the Ensuring Community Access to Pharmacist Services Act; Draft legislation to amend title XVIII of the Social Security Act to modify the conversion factor updates applicable to physicians' services under the Medicare program; Implementation of Centers for Medicare & Medicaid Services. (2025). Medicare and Medicaid Programs; CY 2026 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program. Federal Register, 88, 90 FR 49266-50481; H.R. 6160, the Strengthening Medicare for Patients and Providers Act; H.R. 8163, the Provider Reimbursement Stability Act; H.R. 7520, the Efficiency Adjustment Delay Act; H.R. 8622, the Medicare Physician Data-driven Performance Payment System Act of 2026 H.R.9693, Patients First Act of 2026 H.R.4331, Access to Claims Data Act Proposed CY 2027 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program
Provider Reimbursement Stability Act of 2026
Client: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION · Firm: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION
H.R. 879/S. 1640, the Medicare Patient Access and Practice Stabilization Act of 2025; H.R. 1, the One Big Beautiful Bill Act; H.R. 3164/S. 2426, the Ensuring Community Access to Pharmacist Services Act; Draft legislation to amend title XVIII of the Social Security Act to modify the conversion factor updates applicable to physicians' services under the Medicare program; Implementation of Centers for Medicare & Medicaid Services. (2025). Medicare and Medicaid Programs; CY 2026 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program. Federal Register, 88, 90 FR 49266-50481; H.R. 6160, the Strengthening Medicare for Patients and Providers Act; H.R. 8163, the Provider Reimbursement Stability Act
Provider Reimbursement Stability Act of 2026
Client: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION · Firm: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION
H.R. 879/S. 1640, the Medicare Patient Access and Practice Stabilization Act of 2025; H.R. 1, the One Big Beautiful Bill Act; H.R. 3164/S. 2426, the Ensuring Community Access to Pharmacist Services Act; Draft legislation to amend title XVIII of the Social Security Act to modify the conversion factor updates applicable to physicians' services under the Medicare program; Implementation of Centers for Medicare & Medicaid Services. (2025). Medicare and Medicaid Programs; CY 2026 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program. Federal Register, 88, 90 FR 49266-50481; H.R. 6160, the Strengthening Medicare for Patients and Providers Act; H.R. 8163, the Provider Reimbursement Stability Act; H.R. 7520, the Efficiency Adjustment Delay Act; H.R. 8622, the Medicare Physician Data-driven Performance Payment System Act of 2026 H.R.9693, Patients First Act of 2026 H.R.4331, Access to Claims Data Act Proposed CY 2027 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program
Provider Reimbursement Stability Act of 2026
Client: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION · Firm: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION
H.R. 879/S. 1640, the Medicare Patient Access and Practice Stabilization Act of 2025; H.R. 1, the One Big Beautiful Bill Act; H.R. 3164/S. 2426, the Ensuring Community Access to Pharmacist Services Act; Draft legislation to amend title XVIII of the Social Security Act to modify the conversion factor updates applicable to physicians' services under the Medicare program; Implementation of Centers for Medicare & Medicaid Services. (2025). Medicare and Medicaid Programs; CY 2026 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program. Federal Register, 88, 90 FR 49266-50481; H.R. 6160, the Strengthening Medicare for Patients and Providers Act; H.R. 8163, the Provider Reimbursement Stability Act; H.R. 7520, the Efficiency Adjustment Delay Act; H.R. 8622, the Medicare Physician Data-driven Performance Payment System Act of 2026
Medicare Physician Data-driven Performance Payment System Act of 2026
Client: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION · Firm: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION
H.R. 879/S. 1640, the Medicare Patient Access and Practice Stabilization Act of 2025; H.R. 1, the One Big Beautiful Bill Act; H.R. 3164/S. 2426, the Ensuring Community Access to Pharmacist Services Act; Draft legislation to amend title XVIII of the Social Security Act to modify the conversion factor updates applicable to physicians' services under the Medicare program; Implementation of Centers for Medicare & Medicaid Services. (2025). Medicare and Medicaid Programs; CY 2026 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program. Federal Register, 88, 90 FR 49266-50481; H.R. 6160, the Strengthening Medicare for Patients and Providers Act; H.R. 8163, the Provider Reimbursement Stability Act; H.R. 7520, the Efficiency Adjustment Delay Act; H.R. 8622, the Medicare Physician Data-driven Performance Payment System Act of 2026
Medicare Physician Data-driven Performance Payment System Act of 2026
Client: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION · Firm: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION
H.R. 879/S. 1640, the Medicare Patient Access and Practice Stabilization Act of 2025; H.R. 1, the One Big Beautiful Bill Act; H.R. 3164/S. 2426, the Ensuring Community Access to Pharmacist Services Act; Draft legislation to amend title XVIII of the Social Security Act to modify the conversion factor updates applicable to physicians' services under the Medicare program; Implementation of Centers for Medicare & Medicaid Services. (2025). Medicare and Medicaid Programs; CY 2026 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program. Federal Register, 88, 90 FR 49266-50481; H.R. 6160, the Strengthening Medicare for Patients and Providers Act; H.R. 8163, the Provider Reimbursement Stability Act; H.R. 7520, the Efficiency Adjustment Delay Act; H.R. 8622, the Medicare Physician Data-driven Performance Payment System Act of 2026 H.R.9693, Patients First Act of 2026 H.R.4331, Access to Claims Data Act Proposed CY 2027 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program
Medicare Patient Access and Practice Stabilization Act of 2025
Client: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION · Firm: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION
H.R. 879/S. 1640, the Medicare Patient Access and Practice Stabilization Act of 2025; H.R. 1, the One Big Beautiful Bill Act; H.R. 3164/S. 2426, the Ensuring Community Access to Pharmacist Services Act; Draft legislation to amend title XVIII of the Social Security Act to modify the conversion factor updates applicable to physicians' services under the Medicare program; Implementation of Centers for Medicare & Medicaid Services. (2025). Medicare and Medicaid Programs; CY 2026 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program. Federal Register, 88, 90 FR 49266-50481; H.R. 6160, the Strengthening Medicare for Patients and Providers Act; H.R. 8163, the Provider Reimbursement Stability Act
Medicare Patient Access and Practice Stabilization Act of 2025
Client: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION · Firm: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION
H.R. 879/S. 1640, the Medicare Patient Access and Practice Stabilization Act of 2025; H.R. 1, the One Big Beautiful Bill Act; H.R. 3164/S. 2426, the Ensuring Community Access to Pharmacist Services Act; Draft legislation to amend title XVIII of the Social Security Act to modify the conversion factor updates applicable to physicians' services under the Medicare program; Implementation of Centers for Medicare & Medicaid Services. (2025). Medicare and Medicaid Programs; CY 2026 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program. Federal Register, 88, 90 FR 49266-50481; H.R. 6160, the Strengthening Medicare for Patients and Providers Act; H.R. 8163, the Provider Reimbursement Stability Act; H.R. 7520, the Efficiency Adjustment Delay Act; H.R. 8622, the Medicare Physician Data-driven Performance Payment System Act of 2026 H.R.9693, Patients First Act of 2026 H.R.4331, Access to Claims Data Act Proposed CY 2027 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program
Medicare Patient Access and Practice Stabilization Act of 2025
Client: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION · Firm: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION
H.R. 879/S. 1640, the Medicare Patient Access and Practice Stabilization Act of 2025; H.R. 1, the One Big Beautiful Bill Act; H.R. 3164/S. 2426, the Ensuring Community Access to Pharmacist Services Act; Draft legislation to amend title XVIII of the Social Security Act to modify the conversion factor updates applicable to physicians' services under the Medicare program; Implementation of Centers for Medicare & Medicaid Services. (2025). Medicare and Medicaid Programs; CY 2026 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program. Federal Register, 88, 90 FR 49266-50481; H.R. 6160, the Strengthening Medicare for Patients and Providers Act; H.R. 8163, the Provider Reimbursement Stability Act; H.R. 7520, the Efficiency Adjustment Delay Act; H.R. 8622, the Medicare Physician Data-driven Performance Payment System Act of 2026
Patients First Act of 2026
Client: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION · Firm: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION
H.R. 879/S. 1640, the Medicare Patient Access and Practice Stabilization Act of 2025; H.R. 1, the One Big Beautiful Bill Act; H.R. 3164/S. 2426, the Ensuring Community Access to Pharmacist Services Act; Draft legislation to amend title XVIII of the Social Security Act to modify the conversion factor updates applicable to physicians' services under the Medicare program; Implementation of Centers for Medicare & Medicaid Services. (2025). Medicare and Medicaid Programs; CY 2026 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program. Federal Register, 88, 90 FR 49266-50481; H.R. 6160, the Strengthening Medicare for Patients and Providers Act; H.R. 8163, the Provider Reimbursement Stability Act; H.R. 7520, the Efficiency Adjustment Delay Act; H.R. 8622, the Medicare Physician Data-driven Performance Payment System Act of 2026 H.R.9693, Patients First Act of 2026 H.R.4331, Access to Claims Data Act Proposed CY 2027 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program
Medicare Patient Access and Practice Stabilization Act of 2025
Client: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION · Firm: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION
H.R. 879/S. 1640, the Medicare Patient Access and Practice Stabilization Act of 2025; H.R. 1, the One Big Beautiful Bill Act; H.R. 3164/S. 2426, the Ensuring Community Access to Pharmacist Services Act; Draft legislation to amend title XVIII of the Social Security Act to modify the conversion factor updates applicable to physicians' services under the Medicare program; Implementation of Centers for Medicare & Medicaid Services. (2025). Medicare and Medicaid Programs; CY 2026 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program. Federal Register, 88, 90 FR 49266-50481; H.R. 6160, the Strengthening Medicare for Patients and Providers Act; H.R. 8163, the Provider Reimbursement Stability Act
Medicare Patient Access and Practice Stabilization Act of 2025
Client: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION · Firm: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION
H.R. 879/S. 1640, the Medicare Patient Access and Practice Stabilization Act of 2025; H.R. 1, the One Big Beautiful Bill Act; H.R. 3164/S. 2426, the Ensuring Community Access to Pharmacist Services Act; Draft legislation to amend title XVIII of the Social Security Act to modify the conversion factor updates applicable to physicians' services under the Medicare program; Implementation of Centers for Medicare & Medicaid Services. (2025). Medicare and Medicaid Programs; CY 2026 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program. Federal Register, 88, 90 FR 49266-50481; H.R. 6160, the Strengthening Medicare for Patients and Providers Act; H.R. 8163, the Provider Reimbursement Stability Act; H.R. 7520, the Efficiency Adjustment Delay Act; H.R. 8622, the Medicare Physician Data-driven Performance Payment System Act of 2026
Medicare Patient Access and Practice Stabilization Act of 2025
Client: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION · Firm: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION
H.R. 879/S. 1640, the Medicare Patient Access and Practice Stabilization Act of 2025; H.R. 1, the One Big Beautiful Bill Act; H.R. 3164/S. 2426, the Ensuring Community Access to Pharmacist Services Act; Draft legislation to amend title XVIII of the Social Security Act to modify the conversion factor updates applicable to physicians' services under the Medicare program; Implementation of Centers for Medicare & Medicaid Services. (2025). Medicare and Medicaid Programs; CY 2026 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program. Federal Register, 88, 90 FR 49266-50481; H.R. 6160, the Strengthening Medicare for Patients and Providers Act; H.R. 8163, the Provider Reimbursement Stability Act; H.R. 7520, the Efficiency Adjustment Delay Act; H.R. 8622, the Medicare Physician Data-driven Performance Payment System Act of 2026 H.R.9693, Patients First Act of 2026 H.R.4331, Access to Claims Data Act Proposed CY 2027 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program
Over-the-Counter Monograph Drug User Fee Amendments
Client: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION · Firm: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION
H.R. 3686, the SAFE Sunscreen Standards Act; H.R. 4273/S. 2292, Over-the-Counter Monograph Drug User Fee Amendments; H.R. 5509/S. 2903, the Safe Step Act; H.R. 4002, the Patient Access to Higher Quality Health Care Act of 2025 Clinical Laboratory Improvement Amendment
Over-the-Counter Monograph Drug User Fee Amendments
Client: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION · Firm: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION
H.R. 3686, the SAFE Sunscreen Standards Act; H.R. 4273/S. 2292, Over-the-Counter Monograph Drug User Fee Amendments; H.R. 5509/S. 2903, the Safe Step Act; H.R. 4002, the Patient Access to Higher Quality Health Care Act of 2025
Over-the-Counter Monograph Drug User Fee Amendments
Client: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION · Firm: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION
H.R. 3686, the SAFE Sunscreen Standards Act; H.R. 4273/S. 2292, Over-the-Counter Monograph Drug User Fee Amendments; H.R. 5509/S. 2903, the Safe Step Act; H.R. 4002, the Patient Access to Higher Quality Health Care Act of 2025
Equitable Community Access to Pharmacist Services Act
Client: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION · Firm: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION
H.R. 879/S. 1640, the Medicare Patient Access and Practice Stabilization Act of 2025; H.R. 1, the One Big Beautiful Bill Act; H.R. 3164/S. 2426, the Ensuring Community Access to Pharmacist Services Act; Draft legislation to amend title XVIII of the Social Security Act to modify the conversion factor updates applicable to physicians' services under the Medicare program; Implementation of Centers for Medicare & Medicaid Services. (2025). Medicare and Medicaid Programs; CY 2026 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program. Federal Register, 88, 90 FR 49266-50481; H.R. 6160, the Strengthening Medicare for Patients and Providers Act; H.R. 8163, the Provider Reimbursement Stability Act; H.R. 7520, the Efficiency Adjustment Delay Act; H.R. 8622, the Medicare Physician Data-driven Performance Payment System Act of 2026
Equitable Community Access to Pharmacist Services Act
Client: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION · Firm: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION
H.R. 879/S. 1640, the Medicare Patient Access and Practice Stabilization Act of 2025; H.R. 1, the One Big Beautiful Bill Act; H.R. 3164/S. 2426, the Ensuring Community Access to Pharmacist Services Act; Draft legislation to amend title XVIII of the Social Security Act to modify the conversion factor updates applicable to physicians' services under the Medicare program; Implementation of Centers for Medicare & Medicaid Services. (2025). Medicare and Medicaid Programs; CY 2026 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program. Federal Register, 88, 90 FR 49266-50481; H.R. 6160, the Strengthening Medicare for Patients and Providers Act; H.R. 8163, the Provider Reimbursement Stability Act; H.R. 7520, the Efficiency Adjustment Delay Act; H.R. 8622, the Medicare Physician Data-driven Performance Payment System Act of 2026 H.R.9693, Patients First Act of 2026 H.R.4331, Access to Claims Data Act Proposed CY 2027 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program
Equitable Community Access to Pharmacist Services Act
Client: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION · Firm: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION
H.R. 879/S. 1640, the Medicare Patient Access and Practice Stabilization Act of 2025; H.R. 1, the One Big Beautiful Bill Act; H.R. 3164/S. 2426, the Ensuring Community Access to Pharmacist Services Act; Draft legislation to amend title XVIII of the Social Security Act to modify the conversion factor updates applicable to physicians' services under the Medicare program; Implementation of Centers for Medicare & Medicaid Services. (2025). Medicare and Medicaid Programs; CY 2026 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program. Federal Register, 88, 90 FR 49266-50481; H.R. 6160, the Strengthening Medicare for Patients and Providers Act; H.R. 8163, the Provider Reimbursement Stability Act
Safe Step Act
Client: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION · Firm: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION
H.R. 3686, the SAFE Sunscreen Standards Act; H.R. 4273/S. 2292, Over-the-Counter Monograph Drug User Fee Amendments; H.R. 5509/S. 2903, the Safe Step Act; H.R. 4002, the Patient Access to Higher Quality Health Care Act of 2025
Safe Step Act
Client: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION · Firm: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION
H.R. 3686, the SAFE Sunscreen Standards Act; H.R. 4273/S. 2292, Over-the-Counter Monograph Drug User Fee Amendments; H.R. 5509/S. 2903, the Safe Step Act; H.R. 4002, the Patient Access to Higher Quality Health Care Act of 2025
Safe Step Act
Client: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION · Firm: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION
H.R. 3686, the SAFE Sunscreen Standards Act; H.R. 4273/S. 2292, Over-the-Counter Monograph Drug User Fee Amendments; H.R. 5509/S. 2903, the Safe Step Act; H.R. 4002, the Patient Access to Higher Quality Health Care Act of 2025 Clinical Laboratory Improvement Amendment
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION · Firm: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION
H.R. 879/S. 1640, the Medicare Patient Access and Practice Stabilization Act of 2025; H.R. 1, the One Big Beautiful Bill Act; H.R. 3164/S. 2426, the Ensuring Community Access to Pharmacist Services Act; Draft legislation to amend title XVIII of the Social Security Act to ensure stability for provider payments under the Medicare program; Draft legislation to amend title XVIII of the Social Security Act to modify the conversion factor updates applicable to physicians' services under the Medicare program; Implementation of Centers for Medicare & Medicaid Services. (2025). Medicare and Medicaid Programs; CY 2026 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program. Federal Register, 88, 90 FR 49266-50481; H.R. 6160, the Strengthening Medicare for Patients and Providers Act
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION · Firm: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION
H.R. 1940, the Tanning Tax Repeal Act of 2025; H.R. 1, the One Big Beautiful Bill Act
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION · Firm: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION
H.R. 879/S. 1640, the Medicare Patient Access and Practice Stabilization Act of 2025; H.R. 1, the One Big Beautiful Bill Act
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION · Firm: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION
H.R. 1940, the Tanning Tax Repeal Act of 2025; H.R. 1, the One Big Beautiful Bill Act
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION · Firm: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION
H.R. 1940, the Tanning Tax Repeal Act of 2025; H.R. 1, the One Big Beautiful Bill Act
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION · Firm: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION
H.R. 879/S. 1640, the Medicare Patient Access and Practice Stabilization Act of 2025; H.R. 1, the One Big Beautiful Bill Act; H.R. 3164/S. 2426, the Ensuring Community Access to Pharmacist Services Act; Draft legislation to amend title XVIII of the Social Security Act to ensure stability for provider payments under the Medicare program; Draft legislation to amend title XVIII of the Social Security Act to modify the conversion factor updates applicable to physicians' services under the Medicare program
Tanning Tax Repeal Act of 2025
Client: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION · Firm: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION
H.R. 1940, the Tanning Tax Repeal Act of 2025; H.R. 1, the One Big Beautiful Bill Act
Tanning Tax Repeal Act of 2025
Client: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION · Firm: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION
H.R. 1940, the Tanning Tax Repeal Act of 2025; H.R. 1, the One Big Beautiful Bill Act
Tanning Tax Repeal Act of 2025
Client: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION · Firm: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION
H.R. 1940, the Tanning Tax Repeal Act of 2025; H.R. 1, the One Big Beautiful Bill Act
Full-Year Continuing Appropriations and Extensions Act, 2025
Client: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION · Firm: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION
H.R. 1968, the Full-Year Continuing Appropriations and Extensions Act, 2025
Full-Year Continuing Appropriations and Extensions Act, 2025
Client: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION · Firm: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION
H.R. 1968, the Full-Year Continuing Appropriations and Extensions Act, 2025
Full-Year Continuing Appropriations and Extensions Act, 2025
Client: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION · Firm: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION
H.R. 1968, the Full-Year Continuing Appropriations and Extensions Act, 2025
Full-Year Continuing Appropriations and Extensions Act, 2025
Client: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION · Firm: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION
H.R. 1968, the Full-Year Continuing Appropriations and Extensions Act, 2025
Ensuring Community Access to Pharmacist Services Act
Client: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION · Firm: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION
H.R. 879/S. 1640, the Medicare Patient Access and Practice Stabilization Act of 2025; H.R. 1, the One Big Beautiful Bill Act; H.R. 3164/S. 2426, the Ensuring Community Access to Pharmacist Services Act; Draft legislation to amend title XVIII of the Social Security Act to ensure stability for provider payments under the Medicare program; Draft legislation to amend title XVIII of the Social Security Act to modify the conversion factor updates applicable to physicians' services under the Medicare program
Ensuring Community Access to Pharmacist Services Act
Client: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION · Firm: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION
H.R. 879/S. 1640, the Medicare Patient Access and Practice Stabilization Act of 2025; H.R. 1, the One Big Beautiful Bill Act; H.R. 3164/S. 2426, the Ensuring Community Access to Pharmacist Services Act; Draft legislation to amend title XVIII of the Social Security Act to ensure stability for provider payments under the Medicare program; Draft legislation to amend title XVIII of the Social Security Act to modify the conversion factor updates applicable to physicians' services under the Medicare program; Implementation of Centers for Medicare & Medicaid Services. (2025). Medicare and Medicaid Programs; CY 2026 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program. Federal Register, 88, 90 FR 49266-50481; H.R. 6160, the Strengthening Medicare for Patients and Providers Act
SAFE Sunscreen Standards Act
Client: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION · Firm: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION
H.R. 3686, the SAFE Sunscreen Standards Act
SAFE Sunscreen Standards Act
Client: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION · Firm: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION
H.R. 3686, the SAFE Sunscreen Standards Act; H.R. 4273/S. 2292, Over-the-Counter Monograph Drug User Fee Amendments; H.R. 5509/S. 2903, the Safe Step Act
SAFE Sunscreen Standards Act
Client: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION · Firm: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION
H.R. 3686, the SAFE Sunscreen Standards Act; H.R. 4273/S. 2292, Over-the-Counter Monograph Drug User Fee Amendments; H.R. 5509/S. 2903, the Safe Step Act; H.R. 4002, the Patient Access to Higher Quality Health Care Act of 2025
Patient Access to Higher Quality Health Care Act of 2025
Client: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION · Firm: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION
H.R. 3686, the SAFE Sunscreen Standards Act; H.R. 4273/S. 2292, Over-the-Counter Monograph Drug User Fee Amendments; H.R. 5509/S. 2903, the Safe Step Act; H.R. 4002, the Patient Access to Higher Quality Health Care Act of 2025
Over-the-Counter Monograph Drug User Fee Amendments
Client: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION · Firm: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION
H.R. 3686, the SAFE Sunscreen Standards Act; H.R. 4273/S. 2292, Over-the-Counter Monograph Drug User Fee Amendments; H.R. 5509/S. 2903, the Safe Step Act; H.R. 4002, the Patient Access to Higher Quality Health Care Act of 2025
Over-the-Counter Monograph Drug User Fee Amendments
Client: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION · Firm: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION
H.R. 3686, the SAFE Sunscreen Standards Act; H.R. 4273/S. 2292, Over-the-Counter Monograph Drug User Fee Amendments; H.R. 5509/S. 2903, the Safe Step Act
Safe Step Act
Client: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION · Firm: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION
H.R. 3686, the SAFE Sunscreen Standards Act; H.R. 4273/S. 2292, Over-the-Counter Monograph Drug User Fee Amendments; H.R. 5509/S. 2903, the Safe Step Act
Safe Step Act
Client: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION · Firm: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION
H.R. 3686, the SAFE Sunscreen Standards Act; H.R. 4273/S. 2292, Over-the-Counter Monograph Drug User Fee Amendments; H.R. 5509/S. 2903, the Safe Step Act; H.R. 4002, the Patient Access to Higher Quality Health Care Act of 2025
Strengthening Medicare for Patients and Providers Act
Client: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION · Firm: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION
H.R. 879/S. 1640, the Medicare Patient Access and Practice Stabilization Act of 2025; H.R. 1, the One Big Beautiful Bill Act; H.R. 3164/S. 2426, the Ensuring Community Access to Pharmacist Services Act; Draft legislation to amend title XVIII of the Social Security Act to ensure stability for provider payments under the Medicare program; Draft legislation to amend title XVIII of the Social Security Act to modify the conversion factor updates applicable to physicians' services under the Medicare program; Implementation of Centers for Medicare & Medicaid Services. (2025). Medicare and Medicaid Programs; CY 2026 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program. Federal Register, 88, 90 FR 49266-50481; H.R. 6160, the Strengthening Medicare for Patients and Providers Act
Medicare Patient Access and Practice Stabilization Act of 2025
Client: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION · Firm: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION
H.R. 879/S. 1640, the Medicare Patient Access and Practice Stabilization Act of 2025; H.R. 1, the One Big Beautiful Bill Act; H.R. 3164/S. 2426, the Ensuring Community Access to Pharmacist Services Act; Draft legislation to amend title XVIII of the Social Security Act to ensure stability for provider payments under the Medicare program; Draft legislation to amend title XVIII of the Social Security Act to modify the conversion factor updates applicable to physicians' services under the Medicare program
Medicare Patient Access and Practice Stabilization Act of 2025
Client: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION · Firm: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION
H.R. 879, the Medicare Patient Access and Practice Stabilization Act of 2025
Medicare Patient Access and Practice Stabilization Act of 2025
Client: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION · Firm: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION
H.R. 879/S. 1640, the Medicare Patient Access and Practice Stabilization Act of 2025; H.R. 1, the One Big Beautiful Bill Act
Medicare Patient Access and Practice Stabilization Act of 2025
Client: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION · Firm: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION
H.R. 879/S. 1640, the Medicare Patient Access and Practice Stabilization Act of 2025; H.R. 1, the One Big Beautiful Bill Act; H.R. 3164/S. 2426, the Ensuring Community Access to Pharmacist Services Act; Draft legislation to amend title XVIII of the Social Security Act to ensure stability for provider payments under the Medicare program; Draft legislation to amend title XVIII of the Social Security Act to modify the conversion factor updates applicable to physicians' services under the Medicare program; Implementation of Centers for Medicare & Medicaid Services. (2025). Medicare and Medicaid Programs; CY 2026 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program. Federal Register, 88, 90 FR 49266-50481; H.R. 6160, the Strengthening Medicare for Patients and Providers Act
Medicare Patient Access and Practice Stabilization Act of 2025
Client: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION · Firm: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION
H.R. 879/S. 1640, the Medicare Patient Access and Practice Stabilization Act of 2025; H.R. 1, the One Big Beautiful Bill Act; H.R. 3164/S. 2426, the Ensuring Community Access to Pharmacist Services Act; Draft legislation to amend title XVIII of the Social Security Act to ensure stability for provider payments under the Medicare program; Draft legislation to amend title XVIII of the Social Security Act to modify the conversion factor updates applicable to physicians' services under the Medicare program; Implementation of Centers for Medicare & Medicaid Services. (2025). Medicare and Medicaid Programs; CY 2026 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program. Federal Register, 88, 90 FR 49266-50481; H.R. 6160, the Strengthening Medicare for Patients and Providers Act
Medicare Patient Access and Practice Stabilization Act of 2025
Client: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION · Firm: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION
H.R. 879/S. 1640, the Medicare Patient Access and Practice Stabilization Act of 2025; H.R. 1, the One Big Beautiful Bill Act; H.R. 3164/S. 2426, the Ensuring Community Access to Pharmacist Services Act; Draft legislation to amend title XVIII of the Social Security Act to ensure stability for provider payments under the Medicare program; Draft legislation to amend title XVIII of the Social Security Act to modify the conversion factor updates applicable to physicians' services under the Medicare program
Medicare Patient Access and Practice Stabilization Act of 2025
Client: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION · Firm: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION
H.R. 879/S. 1640, the Medicare Patient Access and Practice Stabilization Act of 2025; H.R. 1, the One Big Beautiful Bill Act
Over-the-Counter Monograph Drug User Fee Amendments
Client: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION · Firm: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION
H.R. 3686, the SAFE Sunscreen Standards Act; H.R. 4273/S. 2292, Over-the-Counter Monograph Drug User Fee Amendments; H.R. 5509/S. 2903, the Safe Step Act
Over-the-Counter Monograph Drug User Fee Amendments
Client: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION · Firm: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION
H.R. 3686, the SAFE Sunscreen Standards Act; H.R. 4273/S. 2292, Over-the-Counter Monograph Drug User Fee Amendments; H.R. 5509/S. 2903, the Safe Step Act; H.R. 4002, the Patient Access to Higher Quality Health Care Act of 2025
Equitable Community Access to Pharmacist Services Act
Client: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION · Firm: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION
H.R. 879/S. 1640, the Medicare Patient Access and Practice Stabilization Act of 2025; H.R. 1, the One Big Beautiful Bill Act; H.R. 3164/S. 2426, the Ensuring Community Access to Pharmacist Services Act; Draft legislation to amend title XVIII of the Social Security Act to ensure stability for provider payments under the Medicare program; Draft legislation to amend title XVIII of the Social Security Act to modify the conversion factor updates applicable to physicians' services under the Medicare program; Implementation of Centers for Medicare & Medicaid Services. (2025). Medicare and Medicaid Programs; CY 2026 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program. Federal Register, 88, 90 FR 49266-50481; H.R. 6160, the Strengthening Medicare for Patients and Providers Act
Equitable Community Access to Pharmacist Services Act
Client: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION · Firm: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION
H.R. 879/S. 1640, the Medicare Patient Access and Practice Stabilization Act of 2025; H.R. 1, the One Big Beautiful Bill Act; H.R. 3164/S. 2426, the Ensuring Community Access to Pharmacist Services Act; Draft legislation to amend title XVIII of the Social Security Act to ensure stability for provider payments under the Medicare program; Draft legislation to amend title XVIII of the Social Security Act to modify the conversion factor updates applicable to physicians' services under the Medicare program
Safe Step Act
Client: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION · Firm: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION
H.R. 3686, the SAFE Sunscreen Standards Act; H.R. 4273/S. 2292, Over-the-Counter Monograph Drug User Fee Amendments; H.R. 5509/S. 2903, the Safe Step Act
Safe Step Act
Client: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION · Firm: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION
H.R. 3686, the SAFE Sunscreen Standards Act; H.R. 4273/S. 2292, Over-the-Counter Monograph Drug User Fee Amendments; H.R. 5509/S. 2903, the Safe Step Act; H.R. 4002, the Patient Access to Higher Quality Health Care Act of 2025
Medicare Patient Access and Practice Stabilization Act of 2024
Client: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION · Firm: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION
Advocate for adequate and accurate network coverage for dermatologic care within Medicare Advantage. Advocate for increased funding and reforms to Graduate Medical Education. Advocate for improvements to Health Information Technology implementation. Advocate for expansion of telemedicine services under Medicare and increased reimbursement for such services. Advocate for improving disease management and care coordination for patients with chronic diseases. Advocate for relief from Medicare regulations under Medicare Access and CHIP Reauthorization Act (MACRA P.L. 114-110), including the Quality Payment Program (QPP) and specifically the development of advanced alternative payment models (APMs) and implementation of the Merit-Based Incentive Payment System (MIPS). Advocate for Congress to urge CMS to strengthen Qualified Clinical Data Registries (QCDRs) by removing barriers that restrict access to data from EHRs. Advocate for congressional action to hold health care professionals harmless from any cuts related to CMS Evaluation and Management Code proposals in any forthcoming legislative package. Advocate to replace scheduled and anticipated cuts in Medicare payments with positive, inflationary-based updates, eliminate the anticipated conversion factor cut in the CMS proposed rule for the 2024 Medicare Physician Fee Schedule (MPFS) associated with budget neutrality adjustments tied to Evaluation & Management (E/M) Code MPFS policy changes. Support H.R.2474, Strengthening Medicare for Patients and Providers Act. Support H.R. 3674, the Providing Relief and Stability for Medicare Patients Act of 2023. Support the Resident Physician Shortage Reduction Act (S. 1302/H.R. 2389). Advocate regarding matters related to Merit-based Incentive Payment System (MIPS), MIPS Value Pathways (MVPs), and Qualified Clinical Data Registries. H.R. 5213, the Reducing Medically Unnecessary Delays in Care Act of 2023. H.R. 6445/S.2377, the Medicare Audiology Access Improvement Act of 2023. H.R. 6487/S.3805, the No Fees for EFTs Act. H.R. 6545, the Physician Fee Schedule Update and Improvements Act. H.R. 6683, the Preserving Seniors' Access to Physicians Act of 2023; Draft legislation, To amend title XVIII of the Social Security Act to transform the Merit-based Incentive Payment System into the Data-Driven Performance Payment System under the Medicare physician fee schedule, and for other purposes; H.R. 8702/S. 4532, the Improving Seniors Timely Access to Care Act; S. 3503/H.R. 5013, Value in Health Care Act; S. 4935, Physician Fee Stability Act; S. 2477/H.R. 1770, Equitable Community Access to Pharmacist Services Act; H.R. 10073, the Medicare Patient Access and Practice Stabilization Act of 2024; H.R. 10545, the American Relief Act, 2025
American Relief Act, 2025
Client: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION · Firm: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION
Advocate for adequate and accurate network coverage for dermatologic care within Medicare Advantage. Advocate for increased funding and reforms to Graduate Medical Education. Advocate for improvements to Health Information Technology implementation. Advocate for expansion of telemedicine services under Medicare and increased reimbursement for such services. Advocate for improving disease management and care coordination for patients with chronic diseases. Advocate for relief from Medicare regulations under Medicare Access and CHIP Reauthorization Act (MACRA P.L. 114-110), including the Quality Payment Program (QPP) and specifically the development of advanced alternative payment models (APMs) and implementation of the Merit-Based Incentive Payment System (MIPS). Advocate for Congress to urge CMS to strengthen Qualified Clinical Data Registries (QCDRs) by removing barriers that restrict access to data from EHRs. Advocate for congressional action to hold health care professionals harmless from any cuts related to CMS Evaluation and Management Code proposals in any forthcoming legislative package. Advocate to replace scheduled and anticipated cuts in Medicare payments with positive, inflationary-based updates, eliminate the anticipated conversion factor cut in the CMS proposed rule for the 2024 Medicare Physician Fee Schedule (MPFS) associated with budget neutrality adjustments tied to Evaluation & Management (E/M) Code MPFS policy changes. Support H.R.2474, Strengthening Medicare for Patients and Providers Act. Support H.R. 3674, the Providing Relief and Stability for Medicare Patients Act of 2023. Support the Resident Physician Shortage Reduction Act (S. 1302/H.R. 2389). Advocate regarding matters related to Merit-based Incentive Payment System (MIPS), MIPS Value Pathways (MVPs), and Qualified Clinical Data Registries. H.R. 5213, the Reducing Medically Unnecessary Delays in Care Act of 2023. H.R. 6445/S.2377, the Medicare Audiology Access Improvement Act of 2023. H.R. 6487/S.3805, the No Fees for EFTs Act. H.R. 6545, the Physician Fee Schedule Update and Improvements Act. H.R. 6683, the Preserving Seniors' Access to Physicians Act of 2023; Draft legislation, To amend title XVIII of the Social Security Act to transform the Merit-based Incentive Payment System into the Data-Driven Performance Payment System under the Medicare physician fee schedule, and for other purposes; H.R. 8702/S. 4532, the Improving Seniors Timely Access to Care Act; S. 3503/H.R. 5013, Value in Health Care Act; S. 4935, Physician Fee Stability Act; S. 2477/H.R. 1770, Equitable Community Access to Pharmacist Services Act; H.R. 10073, the Medicare Patient Access and Practice Stabilization Act of 2024; H.R. 10545, the American Relief Act, 2025
REDI Act
Client: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION · Firm: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION
Lobby members of Congress regarding issues related to telemedicine. Advocate for a stable supply of medications and for mitigation of drug shortages, including lidocaine. Advocate for increased transparency regarding drug pricing. Advocate for reducing barriers to entry of generic drugs into the marketplace. Advocate for transparency on the part of pharmaceutical benefit managers. Advocate for patient access to compounded medications. Advocate for reducing the burdens of utilization management tools, including step therapy and prior authorization for pharmaceuticals and services. Advocate for a stable supply of medications and mitigate drug shortages. Lobby members of the House to join the Congressional Skin Cancer Caucus. Advocate for adequate and accurate network coverage for dermatologic care within health insurance exchange networks. Support H.R. 2630/S. 652, Safe Step Act. Advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans. Advocate for the continued and increased funding of Community Health Centers. Advocate for implementation of surprise medical billing legislation (enacted as part of P.L. 116-260, Consolidated Appropriations Act, 2021, H.R. 133) as intended by Congress. Support H.R. 5894/S. 2624. Support H.R. 1202/S. 704, Resident Education Deferred Interest Act or the REDI Act Support H.R. 2389/S1032, the Resident Physician Shortage Reduction Act Lobbied Congress on physician workforce, administrative burden, and workforce diversity issues Advocate for the FDA to implement the 2015 rule, General and Plastic Surgery Devices: Restricted Sale, Distribution, and Use of Sunlamp Products; and the Sunlamp Products Proposed; Amendment to Performance Standard, which would ban minors under the age of 18 from using tanning beds. Advocate for implementation of language to direct the Secretary of Health and Human Services to open a public docket for the submission of public comments regarding factors that should be taken into consideration when reviewing a proposed modification to an approved risk evaluation and mitigation strategy, and for other purposes (enacted as part of P.L. 117-328, Consolidated Appropriations Act, 2023, H.R. 2617). Advocate to replace scheduled and anticipated cuts in Medicare payments with positive, inflationary-based updates, eliminate the anticipated conversion factor cut in the CMS proposed rule for the 2024 Medicare Physician Fee Schedule (MPFS) associated with budget neutrality adjustments tied to Evaluation & Management (E/M) Code MPFS policy changes Advocate against H.R 618, Improving Access to Workers Compensation for Injured Federal Workers Act, which expands the role of nurse practitioners and physician assistants in providing services to injured federal workers under the federal workers' compensation program. Lobbied Congress on impact of the burden of small business issues impacting small physician practices, including Medicare reimbursement cuts. Advocate for H. Res. 365, in support of efforts to curb the incidences of skin cancer beginning with childhood skin protection. Support H.R.2474, Strengthening Medicare for Patients and Providers Act. Support H.R. 2761, S. 705, Specialty Physicians Advancing Rural Care Act (SPARC Act). Support H.R. 4402, Protecting and Continuing Physician Education and Patient Care Act Support H.R. 830/S. 1375, the Help Ensure Lower Patient (HELP) Copays Act. Support H.R. 3674, the Providing Relief and Stability for Medicare Patients Act of 2023. Support S. 935, the Fair Accountability & Innovative Research (FAIR) Drug Pricing Act. Support H.R. 4968, Getting Over Lengthy Delays in Care as Required by Doctors (GOLD CARD) Act. Support H.R.2389/S.1302, the Resident Physicians Shortage Reduction Act. Advocate regarding matters related to Merit-based Incentive Payment System (MIPS), MIPS Value Pathways (MVPs), and Qualified Clinical Data Registries. Advocate regarding AADA efforts in skin cancer prevention and AADA skin cancer prevention programs and initiatives. H.R.7153/S.3679, the Dr. Lorna Breen Health Care Provider Protection Reauthorization Act. S.Res.567/H.Res.1089, a resolution recognizing the seriousness of widespread health care worker burnout in the United States and the need to strengthen health workforce well-being, and expressing support for the designation of March 18, 2024, as the inaugural "Health Workforce Well-Being Day of Awareness".; H.R. 2819, Good Samaritan Health Professionals Act; S. 4349, Electronic Prior Authorization for Prescription Drugs Act
REDI Act
Client: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION · Firm: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION
Lobby members of Congress regarding issues related to telemedicine. Advocate for a stable supply of medications and for mitigation of drug shortages, including lidocaine. Advocate for increased transparency regarding drug pricing. Advocate for reducing barriers to entry of generic drugs into the marketplace. Advocate for transparency on the part of pharmaceutical benefit managers. Advocate for patient access to compounded medications. Advocate for reducing the burdens of utilization management tools, including step therapy and prior authorization for pharmaceuticals and services. Advocate for a stable supply of medications and mitigate drug shortages. Lobby members of the House to join the Congressional Skin Cancer Caucus. Advocate for adequate and accurate network coverage for dermatologic care within health insurance exchange networks. Support H.R. 2630/S. 652, Safe Step Act. Advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans. Advocate for the continued and increased funding of Community Health Centers. Advocate for implementation of surprise medical billing legislation (enacted as part of P.L. 116-260, Consolidated Appropriations Act, 2021, H.R. 133) as intended by Congress. Support H.R. 5894/S. 2624. Support H.R. 1202/S. 704, Resident Education Deferred Interest Act or the REDI Act Support H.R. 2389/S1032, the Resident Physician Shortage Reduction Act Lobbied Congress on physician workforce, administrative burden, and workforce diversity issues Advocate for the FDA to implement the 2015 rule, General and Plastic Surgery Devices: Restricted Sale, Distribution, and Use of Sunlamp Products; and the Sunlamp Products Proposed; Amendment to Performance Standard, which would ban minors under the age of 18 from using tanning beds. Advocate for implementation of language to direct the Secretary of Health and Human Services to open a public docket for the submission of public comments regarding factors that should be taken into consideration when reviewing a proposed modification to an approved risk evaluation and mitigation strategy, and for other purposes (enacted as part of P.L. 117-328, Consolidated Appropriations Act, 2023, H.R. 2617). Advocate to replace scheduled and anticipated cuts in Medicare payments with positive, inflationary-based updates, eliminate the anticipated conversion factor cut in the CMS proposed rule for the 2024 Medicare Physician Fee Schedule (MPFS) associated with budget neutrality adjustments tied to Evaluation & Management (E/M) Code MPFS policy changes Advocate against H.R 618, Improving Access to Workers Compensation for Injured Federal Workers Act, which expands the role of nurse practitioners and physician assistants in providing services to injured federal workers under the federal workers' compensation program. Lobbied Congress on impact of the burden of small business issues impacting small physician practices, including Medicare reimbursement cuts. Advocate for H. Res. 365, in support of efforts to curb the incidences of skin cancer beginning with childhood skin protection. Support H.R.2474, Strengthening Medicare for Patients and Providers Act. Support H.R. 2761, S. 705, Specialty Physicians Advancing Rural Care Act (SPARC Act). Support H.R. 4402, Protecting and Continuing Physician Education and Patient Care Act Support H.R. 830/S. 1375, the Help Ensure Lower Patient (HELP) Copays Act. Support H.R. 3674, the Providing Relief and Stability for Medicare Patients Act of 2023. Support S. 935, the Fair Accountability & Innovative Research (FAIR) Drug Pricing Act. Support H.R. 4968, Getting Over Lengthy Delays in Care as Required by Doctors (GOLD CARD) Act. Support H.R.2389/S.1302, the Resident Physicians Shortage Reduction Act. Advocate regarding matters related to Merit-based Incentive Payment System (MIPS), MIPS Value Pathways (MVPs), and Qualified Clinical Data Registries. Advocate regarding AADA efforts in skin cancer prevention and AADA skin cancer prevention programs and initiatives. H.R.7153/S.3679, the Dr. Lorna Breen Health Care Provider Protection Reauthorization Act. S.Res.567/H.Res.1089, a resolution recognizing the seriousness of widespread health care worker burnout in the United States and the need to strengthen health workforce well-being, and expressing support for the designation of March 18, 2024, as the inaugural "Health Workforce Well-Being Day of Awareness".
REDI Act
Client: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION · Firm: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION
Lobby members of Congress regarding issues related to telemedicine. Advocate for a stable supply of medications and for mitigation of drug shortages, including lidocaine. Advocate for increased transparency regarding drug pricing. Advocate for reducing barriers to entry of generic drugs into the marketplace. Advocate for transparency on the part of pharmaceutical benefit managers. Advocate for patient access to compounded medications. Advocate for reducing the burdens of utilization management tools, including step therapy and prior authorization for pharmaceuticals and services. Advocate for a stable supply of medications and mitigate drug shortages. Lobby members of the House to join the Congressional Skin Cancer Caucus. Advocate for adequate and accurate network coverage for dermatologic care within health insurance exchange networks. Support H.R. 2630/S. 652, Safe Step Act. Advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans. Advocate for the continued and increased funding of Community Health Centers. Advocate for implementation of surprise medical billing legislation (enacted as part of P.L. 116-260, Consolidated Appropriations Act, 2021, H.R. 133) as intended by Congress. Support H.R. 5894/S. 2624. Support H.R. 1202/S. 704, Resident Education Deferred Interest Act or the REDI Act Support H.R. 2389/S1032, the Resident Physician Shortage Reduction Act Lobbied Congress on physician workforce, administrative burden, and workforce diversity issues Advocate for the FDA to implement the 2015 rule, General and Plastic Surgery Devices: Restricted Sale, Distribution, and Use of Sunlamp Products; and the Sunlamp Products Proposed; Amendment to Performance Standard, which would ban minors under the age of 18 from using tanning beds. Advocate for implementation of language to direct the Secretary of Health and Human Services to open a public docket for the submission of public comments regarding factors that should be taken into consideration when reviewing a proposed modification to an approved risk evaluation and mitigation strategy, and for other purposes (enacted as part of P.L. 117-328, Consolidated Appropriations Act, 2023, H.R. 2617). Advocate to replace scheduled and anticipated cuts in Medicare payments with positive, inflationary-based updates, eliminate the anticipated conversion factor cut in the CMS proposed rule for the 2024 Medicare Physician Fee Schedule (MPFS) associated with budget neutrality adjustments tied to Evaluation & Management (E/M) Code MPFS policy changes Advocate against H.R 618, Improving Access to Workers Compensation for Injured Federal Workers Act, which expands the role of nurse practitioners and physician assistants in providing services to injured federal workers under the federal workers' compensation program. Lobbied Congress on impact of the burden of small business issues impacting small physician practices, including Medicare reimbursement cuts. Advocate for H. Res. 365, in support of efforts to curb the incidences of skin cancer beginning with childhood skin protection. Support H.R.2474, Strengthening Medicare for Patients and Providers Act. Support H.R. 2761, S. 705, Specialty Physicians Advancing Rural Care Act (SPARC Act). Support H.R. 4402, Protecting and Continuing Physician Education and Patient Care Act Support H.R. 830/S. 1375, the Help Ensure Lower Patient (HELP) Copays Act. Support H.R. 3674, the Providing Relief and Stability for Medicare Patients Act of 2023. Support S. 935, the Fair Accountability & Innovative Research (FAIR) Drug Pricing Act. Support H.R. 4968, Getting Over Lengthy Delays in Care as Required by Doctors (GOLD CARD) Act. Support H.R.2389/S.1302, the Resident Physicians Shortage Reduction Act. Advocate regarding matters related to Merit-based Incentive Payment System (MIPS), MIPS Value Pathways (MVPs), and Qualified Clinical Data Registries. Advocate regarding AADA efforts in skin cancer prevention and AADA skin cancer prevention programs and initiatives. H.R.7153/S.3679, the Dr. Lorna Breen Health Care Provider Protection Reauthorization Act. S.Res.567/H.Res.1089, a resolution recognizing the seriousness of widespread health care worker burnout in the United States and the need to strengthen health workforce well-being, and expressing support for the designation of March 18, 2024, as the inaugural "Health Workforce Well-Being Day of Awareness".; H.R. 2819, Good Samaritan Health Professionals Act; S. 4349, Electronic Prior Authorization for Prescription Drugs Act
REDI Act
Client: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION · Firm: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION
Lobby members of Congress regarding issues related to telemedicine. Advocate for a stable supply of medications and for mitigation of drug shortages, including lidocaine. Advocate for increased transparency regarding drug pricing. Advocate for reducing barriers to entry of generic drugs into the marketplace. Advocate for transparency on the part of pharmaceutical benefit managers. Advocate for patient access to compounded medications. Advocate for reducing the burdens of utilization management tools, including step therapy and prior authorization for pharmaceuticals and services. Advocate for a stable supply of medications and mitigate drug shortages. Lobby members of the House to join the Congressional Skin Cancer Caucus. Advocate for adequate and accurate network coverage for dermatologic care within health insurance exchange networks. Support H.R. 2630/S. 652, Safe Step Act. Advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans. Advocate for the continued and increased funding of Community Health Centers. Advocate for implementation of surprise medical billing legislation (enacted as part of P.L. 116-260, Consolidated Appropriations Act, 2021, H.R. 133) as intended by Congress. Support H.R. 5894/S. 2624. Support H.R. 1202/S. 704, Resident Education Deferred Interest Act or the REDI Act Support H.R. 2389/S1032, the Resident Physician Shortage Reduction Act Lobbied Congress on physician workforce, administrative burden, and workforce diversity issues Advocate for the FDA to implement the 2015 rule, General and Plastic Surgery Devices: Restricted Sale, Distribution, and Use of Sunlamp Products; and the Sunlamp Products Proposed; Amendment to Performance Standard, which would ban minors under the age of 18 from using tanning beds. Advocate for implementation of language to direct the Secretary of Health and Human Services to open a public docket for the submission of public comments regarding factors that should be taken into consideration when reviewing a proposed modification to an approved risk evaluation and mitigation strategy, and for other purposes (enacted as part of P.L. 117-328, Consolidated Appropriations Act, 2023, H.R. 2617). Advocate to replace scheduled and anticipated cuts in Medicare payments with positive, inflationary-based updates, eliminate the anticipated conversion factor cut in the CMS proposed rule for the 2024 Medicare Physician Fee Schedule (MPFS) associated with budget neutrality adjustments tied to Evaluation & Management (E/M) Code MPFS policy changes Advocate against H.R 618, Improving Access to Workers Compensation for Injured Federal Workers Act, which expands the role of nurse practitioners and physician assistants in providing services to injured federal workers under the federal workers' compensation program. Lobbied Congress on impact of the burden of small business issues impacting small physician practices, including Medicare reimbursement cuts. Advocate for H. Res. 365, in support of efforts to curb the incidences of skin cancer beginning with childhood skin protection. Support H.R.2474, Strengthening Medicare for Patients and Providers Act. Support H.R. 2761, S. 705, Specialty Physicians Advancing Rural Care Act (SPARC Act). Support H.R. 4402, Protecting and Continuing Physician Education and Patient Care Act Support H.R. 830/S. 1375, the Help Ensure Lower Patient (HELP) Copays Act. Support H.R. 3674, the Providing Relief and Stability for Medicare Patients Act of 2023. Support S. 935, the Fair Accountability & Innovative Research (FAIR) Drug Pricing Act. Support H.R. 4968, Getting Over Lengthy Delays in Care as Required by Doctors (GOLD CARD) Act. Support H.R.2389/S.1302, the Resident Physicians Shortage Reduction Act. Advocate regarding matters related to Merit-based Incentive Payment System (MIPS), MIPS Value Pathways (MVPs), and Qualified Clinical Data Registries. Advocate regarding AADA efforts in skin cancer prevention and AADA skin cancer prevention programs and initiatives. H.R.7153/S.3679, the Dr. Lorna Breen Health Care Provider Protection Reauthorization Act. S.Res.567/H.Res.1089, a resolution recognizing the seriousness of widespread health care worker burnout in the United States and the need to strengthen health workforce well-being, and expressing support for the designation of March 18, 2024, as the inaugural "Health Workforce Well-Being Day of Awareness".
Patient Access to Urgent-Use Pharmacy Compounding Act of 2023
Client: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION · Firm: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION
Lobby members of Congress to implement oversight of the FDA regarding the importance of sunscreen use during the proposed rule to put into effect a final monograph for nonprescription, over-the-counter (OTC) sunscreen drug products. Advocate for a stable supply of medications and mitigate drug shortages. Advocate for increased transparency regarding drug pricing. Advocate for reducing barriers to entry of generic drugs into the marketplace. Advocate for transparency on the part of pharmaceutical benefit managers. Advocate for patient access to compounded medications. Advocate for reducing the burdens of utilization management tools, including step therapy and prior authorization for pharmaceuticals. Advocate for implementation of language to direct the Secretary of Health and Human Services to open a public docket for the submission of public comments regarding factors that should be taken into consideration when reviewing a proposed modification to an approved risk evaluation and mitigation strategy, and for other purposes (enacted as part of P.L. 117-328, Consolidated Appropriations Act, 2023, H.R. 2617). Support S. 127, Pharmacy Benefit Manager Transparency Act Support H.R. 830/ S. 1375, the Help Ensure Lower Patient (HELP) Copays Act. Support S. 935, the Fair Accountability & Innovative Research (FAIR) Drug Pricing Act Support H.R. 2630/S. 652, Safe Step Act. Support H.R. 167, Patient Access to Urgent-Use Pharmacy Compounding Act
Patient Access to Urgent-Use Pharmacy Compounding Act of 2023
Client: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION · Firm: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION
Lobby members of Congress to implement oversight of the FDA regarding the importance of sunscreen use during the proposed rule to put into effect a final monograph for nonprescription, over-the-counter (OTC) sunscreen drug products. Advocate for a stable supply of medications and mitigate drug shortages. Advocate for increased transparency regarding drug pricing. Advocate for reducing barriers to entry of generic drugs into the marketplace. Advocate for transparency on the part of pharmaceutical benefit managers. Advocate for patient access to compounded medications. Advocate for reducing the burdens of utilization management tools, including step therapy and prior authorization for pharmaceuticals. Advocate for implementation of language to direct the Secretary of Health and Human Services to open a public docket for the submission of public comments regarding factors that should be taken into consideration when reviewing a proposed modification to an approved risk evaluation and mitigation strategy, and for other purposes (enacted as part of P.L. 117-328, Consolidated Appropriations Act, 2023, H.R. 2617). Support S. 127, Pharmacy Benefit Manager Transparency Act Support H.R. 830/ S. 1375, the Help Ensure Lower Patient (HELP) Copays Act. Support S. 935, the Fair Accountability & Innovative Research (FAIR) Drug Pricing Act Support H.R. 2630/S. 652, Safe Step Act. Support H.R. 167, Patient Access to Urgent-Use Pharmacy Compounding Act
Patient Access to Urgent-Use Pharmacy Compounding Act of 2023
Client: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION · Firm: AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION
Lobby members of Congress to implement oversight of the FDA regarding the importance of sunscreen use during the proposed rule to put into effect a final monograph for nonprescription, over-the-counter (OTC) sunscreen drug products. Advocate for a stable supply of medications and mitigate drug shortages. Advocate for increased transparency regarding drug pricing. Advocate for reducing barriers to entry of generic drugs into the marketplace. Advocate for transparency on the part of pharmaceutical benefit managers. Advocate for patient access to compounded medications. Advocate for reducing the burdens of utilization management tools, including step therapy and prior authorization for pharmaceuticals. Advocate for implementation of language to direct the Secretary of Health and Human Services to open a public docket for the submission of public comments regarding factors that should be taken into consideration when reviewing a proposed modification to an approved risk evaluation and mitigation strategy, and for other purposes (enacted as part of P.L. 117-328, Consolidated Appropriations Act, 2023, H.R. 2617). Support S. 127, Pharmacy Benefit Manager Transparency Act Support H.R. 830/ S. 1375, the Help Ensure Lower Patient (HELP) Copays Act. Support S. 935, the Fair Accountability & Innovative Research (FAIR) Drug Pricing Act Support H.R. 2630/S. 652, Safe Step Act. Support H.R. 167, Patient Access to Urgent-Use Pharmacy Compounding Act
H.R. 3686, the SAFE Sunscreen Standards Act; H.R. 4273/S. 2292, Over-the-Counter Monograph Drug User Fee Amendments; H.R. 5509/S. 2903, the Safe Step Act; H.R. 4002, the Patient Access to Higher Quality Health Care Act of 2025 Clinical Laboratory Improvement Amendment
H.R. 879/S. 1640, the Medicare Patient Access and Practice Stabilization Act of 2025; H.R. 1, the One Big Beautiful Bill Act; H.R. 3164/S. 2426, the Ensuring Community Access to Pharmacist Services Act; Draft legislation to amend title XVIII of the Social Security Act to modify the conversion factor updates applicable to physicians' services under the Medicare program; Implementation of Centers for Medicare & Medicaid Services. (2025). Medicare and Medicaid Programs; CY 2026 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program. Federal Register, 88, 90 FR 49266-50481; H.R. 6160, the Strengthening Medicare for Patients and Providers Act; H.R. 8163, the Provider Reimbursement Stability Act; H.R. 7520, the Efficiency Adjustment Delay Act; H.R. 8622, the Medicare Physician Data-driven Performance Payment System Act of 2026 H.R.9693, Patients First Act of 2026 H.R.4331, Access to Claims Data Act Proposed CY 2027 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program
Revised military shaving waiver policies; Sunscreen access for servicemembers
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), Office of Policy Development, SENATE, White House Office
AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION via AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION
2026 · second_quarter · Q2
H.R. 1940, the Tanning Tax Repeal Act of 2025; H.R. 1, the One Big Beautiful Bill Act
H.R. 1968, the Full-Year Continuing Appropriations and Extensions Act, 2025
H.R. 3686, the SAFE Sunscreen Standards Act; H.R. 4273/S. 2292, Over-the-Counter Monograph Drug User Fee Amendments; H.R. 5509/S. 2903, the Safe Step Act; H.R. 4002, the Patient Access to Higher Quality Health Care Act of 2025
H.R. 879/S. 1640, the Medicare Patient Access and Practice Stabilization Act of 2025; H.R. 1, the One Big Beautiful Bill Act; H.R. 3164/S. 2426, the Ensuring Community Access to Pharmacist Services Act; Draft legislation to amend title XVIII of the Social Security Act to modify the conversion factor updates applicable to physicians' services under the Medicare program; Implementation of Centers for Medicare & Medicaid Services. (2025). Medicare and Medicaid Programs; CY 2026 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program. Federal Register, 88, 90 FR 49266-50481; H.R. 6160, the Strengthening Medicare for Patients and Providers Act; H.R. 8163, the Provider Reimbursement Stability Act; H.R. 7520, the Efficiency Adjustment Delay Act; H.R. 8622, the Medicare Physician Data-driven Performance Payment System Act of 2026
Revised military shaving waiver policies; Sunscreen access for servicemembers
Filing targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION via AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION
2026 · first_quarter · Q1
H.R. 1940, the Tanning Tax Repeal Act of 2025; H.R. 1, the One Big Beautiful Bill Act
H.R. 1968, the Full-Year Continuing Appropriations and Extensions Act, 2025
Revised military shaving waiver policies
H.R. 879/S. 1640, the Medicare Patient Access and Practice Stabilization Act of 2025; H.R. 1, the One Big Beautiful Bill Act; H.R. 3164/S. 2426, the Ensuring Community Access to Pharmacist Services Act; Draft legislation to amend title XVIII of the Social Security Act to modify the conversion factor updates applicable to physicians' services under the Medicare program; Implementation of Centers for Medicare & Medicaid Services. (2025). Medicare and Medicaid Programs; CY 2026 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program. Federal Register, 88, 90 FR 49266-50481; H.R. 6160, the Strengthening Medicare for Patients and Providers Act; H.R. 8163, the Provider Reimbursement Stability Act
H.R. 3686, the SAFE Sunscreen Standards Act; H.R. 4273/S. 2292, Over-the-Counter Monograph Drug User Fee Amendments; H.R. 5509/S. 2903, the Safe Step Act; H.R. 4002, the Patient Access to Higher Quality Health Care Act of 2025
Filing targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION via AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION
2025 · fourth_quarter · Q4
H.R. 879/S. 1640, the Medicare Patient Access and Practice Stabilization Act of 2025; H.R. 1, the One Big Beautiful Bill Act; H.R. 3164/S. 2426, the Ensuring Community Access to Pharmacist Services Act; Draft legislation to amend title XVIII of the Social Security Act to ensure stability for provider payments under the Medicare program; Draft legislation to amend title XVIII of the Social Security Act to modify the conversion factor updates applicable to physicians' services under the Medicare program; Implementation of Centers for Medicare & Medicaid Services. (2025). Medicare and Medicaid Programs; CY 2026 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program. Federal Register, 88, 90 FR 49266-50481; H.R. 6160, the Strengthening Medicare for Patients and Providers Act
H.R. 1968, the Full-Year Continuing Appropriations and Extensions Act, 2025
H.R. 3686, the SAFE Sunscreen Standards Act; H.R. 4273/S. 2292, Over-the-Counter Monograph Drug User Fee Amendments; H.R. 5509/S. 2903, the Safe Step Act; H.R. 4002, the Patient Access to Higher Quality Health Care Act of 2025
H.R. 1940, the Tanning Tax Repeal Act of 2025; H.R. 1, the One Big Beautiful Bill Act
Revised military shaving waiver policies
Filing targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION via AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION
2025 · third_quarter · Q3
H.R. 879/S. 1640, the Medicare Patient Access and Practice Stabilization Act of 2025; H.R. 1, the One Big Beautiful Bill Act; H.R. 3164/S. 2426, the Ensuring Community Access to Pharmacist Services Act; Draft legislation to amend title XVIII of the Social Security Act to ensure stability for provider payments under the Medicare program; Draft legislation to amend title XVIII of the Social Security Act to modify the conversion factor updates applicable to physicians' services under the Medicare program
H.R. 1968, the Full-Year Continuing Appropriations and Extensions Act, 2025
H.R. 3686, the SAFE Sunscreen Standards Act; H.R. 4273/S. 2292, Over-the-Counter Monograph Drug User Fee Amendments; H.R. 5509/S. 2903, the Safe Step Act
H.R. 1940, the Tanning Tax Repeal Act of 2025; H.R. 1, the One Big Beautiful Bill Act
Revised military shaving waiver policies
Filing targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION via AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION
2025 · second_quarter · Q2
H.R. 879/S. 1640, the Medicare Patient Access and Practice Stabilization Act of 2025; H.R. 1, the One Big Beautiful Bill Act
H.R. 1968, the Full-Year Continuing Appropriations and Extensions Act, 2025
H.R. 3686, the SAFE Sunscreen Standards Act
AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION via AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION
2025 · first_quarter · Q1
H.R. 879, the Medicare Patient Access and Practice Stabilization Act of 2025
H.R. 1968, the Full-Year Continuing Appropriations and Extensions Act, 2025
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION via AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION
2024 · fourth_quarter · Q4
Advocate for medical research and prevention funding for the National Institutes of Health and Centers for Disease Control and Prevention via the FY2024 Labor, Health and Human Services, Education and Related Agencies Appropriations bill (H.R.5894/S.2624). Advocate for adequate funding for the Agency for Healthcare Research and Quality (AHRQ) via the FY2024 Labor, Health and Human Services, Education and Related Agencies Appropriations bill (H.R.5894/S.2624). Advocate for the FDA to implement the 2015 rule, General and Plastic Surgery Devices: Restricted Sale, Distribution, and Use of Sunlamp Products; and the Sunlamp Products Proposed; Amendment to Performance Standard, which would ban minors under the age of 18 from using tanning beds. Advocate to replace scheduled and anticipated cuts in Medicare payments with positive, inflationary-based updates, eliminate the anticipated conversion factor cut in the CMS proposed rule for the 2024 Medicare Physician Fee Schedule (MPFS) associated with budget neutrality adjustments tied to Evaluation & Management (E/M) Code MPFS policy changes. Advocate for increased funding for the Indian Health Services via the FY 2024 Interior-Environment Appropriations bill (H.R.4821/S.2605). Advocate for Defense Health Research Programs (CDMRP) in the FY24 Defense Appropriations Act, specifically the Melanoma Research Program (MRP) (H.R. 4365/S.2587). Advocate for report language studying veterans access to dermatologic care and preventative measures via the FY2024 Veterans Affairs-Military-Construction Appropriations bill (H.R. 4366/S.2127) H.R.4366, the Consolidated Appropriations Act, 2024
AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION via AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION
2024 · third_quarter · Q3
Lobby members of Congress regarding issues related to telemedicine. Advocate for a stable supply of medications and for mitigation of drug shortages, including lidocaine. Advocate for increased transparency regarding drug pricing. Advocate for reducing barriers to entry of generic drugs into the marketplace. Advocate for transparency on the part of pharmaceutical benefit managers. Advocate for patient access to compounded medications. Advocate for reducing the burdens of utilization management tools, including step therapy and prior authorization for pharmaceuticals and services. Advocate for a stable supply of medications and mitigate drug shortages. Lobby members of the House to join the Congressional Skin Cancer Caucus. Advocate for adequate and accurate network coverage for dermatologic care within health insurance exchange networks. Support H.R. 2630/S. 652, Safe Step Act. Advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans. Advocate for the continued and increased funding of Community Health Centers. Advocate for implementation of surprise medical billing legislation (enacted as part of P.L. 116-260, Consolidated Appropriations Act, 2021, H.R. 133) as intended by Congress. Support H.R. 5894/S. 2624. Support H.R. 1202/S. 704, Resident Education Deferred Interest Act or the REDI Act Support H.R. 2389/S1032, the Resident Physician Shortage Reduction Act Lobbied Congress on physician workforce, administrative burden, and workforce diversity issues Advocate for the FDA to implement the 2015 rule, General and Plastic Surgery Devices: Restricted Sale, Distribution, and Use of Sunlamp Products; and the Sunlamp Products Proposed; Amendment to Performance Standard, which would ban minors under the age of 18 from using tanning beds. Advocate for implementation of language to direct the Secretary of Health and Human Services to open a public docket for the submission of public comments regarding factors that should be taken into consideration when reviewing a proposed modification to an approved risk evaluation and mitigation strategy, and for other purposes (enacted as part of P.L. 117-328, Consolidated Appropriations Act, 2023, H.R. 2617). Advocate to replace scheduled and anticipated cuts in Medicare payments with positive, inflationary-based updates, eliminate the anticipated conversion factor cut in the CMS proposed rule for the 2024 Medicare Physician Fee Schedule (MPFS) associated with budget neutrality adjustments tied to Evaluation & Management (E/M) Code MPFS policy changes Advocate against H.R 618, Improving Access to Workers Compensation for Injured Federal Workers Act, which expands the role of nurse practitioners and physician assistants in providing services to injured federal workers under the federal workers' compensation program. Lobbied Congress on impact of the burden of small business issues impacting small physician practices, including Medicare reimbursement cuts. Advocate for H. Res. 365, in support of efforts to curb the incidences of skin cancer beginning with childhood skin protection. Support H.R.2474, Strengthening Medicare for Patients and Providers Act. Support H.R. 2761, S. 705, Specialty Physicians Advancing Rural Care Act (SPARC Act). Support H.R. 4402, Protecting and Continuing Physician Education and Patient Care Act Support H.R. 830/S. 1375, the Help Ensure Lower Patient (HELP) Copays Act. Support H.R. 3674, the Providing Relief and Stability for Medicare Patients Act of 2023. Support S. 935, the Fair Accountability & Innovative Research (FAIR) Drug Pricing Act. Support H.R. 4968, Getting Over Lengthy Delays in Care as Required by Doctors (GOLD CARD) Act. Support H.R.2389/S.1302, the Resident Physicians Shortage Reduction Act. Advocate regarding matters related to Merit-based Incentive Payment System (MIPS), MIPS Value Pathways (MVPs), and Qualified Clinical Data Registries. Advocate regarding AADA efforts in skin cancer prevention and AADA skin cancer prevention programs and initiatives. H.R.7153/S.3679, the Dr. Lorna Breen Health Care Provider Protection Reauthorization Act. S.Res.567/H.Res.1089, a resolution recognizing the seriousness of widespread health care worker burnout in the United States and the need to strengthen health workforce well-being, and expressing support for the designation of March 18, 2024, as the inaugural "Health Workforce Well-Being Day of Awareness".; H.R. 2819, Good Samaritan Health Professionals Act; S. 4349, Electronic Prior Authorization for Prescription Drugs Act
AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION via AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION
2024 · second_quarter · Q2
Lobby members of Congress regarding issues related to telemedicine. Advocate for a stable supply of medications and for mitigation of drug shortages, including lidocaine. Advocate for increased transparency regarding drug pricing. Advocate for reducing barriers to entry of generic drugs into the marketplace. Advocate for transparency on the part of pharmaceutical benefit managers. Advocate for patient access to compounded medications. Advocate for reducing the burdens of utilization management tools, including step therapy and prior authorization for pharmaceuticals and services. Advocate for a stable supply of medications and mitigate drug shortages. Lobby members of the House to join the Congressional Skin Cancer Caucus. Advocate for adequate and accurate network coverage for dermatologic care within health insurance exchange networks. Support H.R. 2630/S. 652, Safe Step Act. Advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans. Advocate for the continued and increased funding of Community Health Centers. Advocate for implementation of surprise medical billing legislation (enacted as part of P.L. 116-260, Consolidated Appropriations Act, 2021, H.R. 133) as intended by Congress. Support H.R. 5894/S. 2624. Support H.R. 1202/S. 704, Resident Education Deferred Interest Act or the REDI Act Support H.R. 2389/S1032, the Resident Physician Shortage Reduction Act Lobbied Congress on physician workforce, administrative burden, and workforce diversity issues Advocate for the FDA to implement the 2015 rule, General and Plastic Surgery Devices: Restricted Sale, Distribution, and Use of Sunlamp Products; and the Sunlamp Products Proposed; Amendment to Performance Standard, which would ban minors under the age of 18 from using tanning beds. Advocate for implementation of language to direct the Secretary of Health and Human Services to open a public docket for the submission of public comments regarding factors that should be taken into consideration when reviewing a proposed modification to an approved risk evaluation and mitigation strategy, and for other purposes (enacted as part of P.L. 117-328, Consolidated Appropriations Act, 2023, H.R. 2617). Advocate to replace scheduled and anticipated cuts in Medicare payments with positive, inflationary-based updates, eliminate the anticipated conversion factor cut in the CMS proposed rule for the 2024 Medicare Physician Fee Schedule (MPFS) associated with budget neutrality adjustments tied to Evaluation & Management (E/M) Code MPFS policy changes Advocate against H.R 618, Improving Access to Workers Compensation for Injured Federal Workers Act, which expands the role of nurse practitioners and physician assistants in providing services to injured federal workers under the federal workers' compensation program. Lobbied Congress on impact of the burden of small business issues impacting small physician practices, including Medicare reimbursement cuts. Advocate for H. Res. 365, in support of efforts to curb the incidences of skin cancer beginning with childhood skin protection. Support H.R.2474, Strengthening Medicare for Patients and Providers Act. Support H.R. 2761, S. 705, Specialty Physicians Advancing Rural Care Act (SPARC Act). Support H.R. 4402, Protecting and Continuing Physician Education and Patient Care Act Support H.R. 830/S. 1375, the Help Ensure Lower Patient (HELP) Copays Act. Support H.R. 3674, the Providing Relief and Stability for Medicare Patients Act of 2023. Support S. 935, the Fair Accountability & Innovative Research (FAIR) Drug Pricing Act. Support H.R. 4968, Getting Over Lengthy Delays in Care as Required by Doctors (GOLD CARD) Act. Support H.R.2389/S.1302, the Resident Physicians Shortage Reduction Act. Advocate regarding matters related to Merit-based Incentive Payment System (MIPS), MIPS Value Pathways (MVPs), and Qualified Clinical Data Registries. Advocate regarding AADA efforts in skin cancer prevention and AADA skin cancer prevention programs and initiatives. H.R.7153/S.3679, the Dr. Lorna Breen Health Care Provider Protection Reauthorization Act. S.Res.567/H.Res.1089, a resolution recognizing the seriousness of widespread health care worker burnout in the United States and the need to strengthen health workforce well-being, and expressing support for the designation of March 18, 2024, as the inaugural "Health Workforce Well-Being Day of Awareness".
AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION via AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION
2024 · first_quarter · Q1
Oppose H.R.936/S.1937, Tanning Tax Repeal Act
Advocate for medical research and prevention funding for the National Institutes of Health and Centers for Disease Control and Prevention via the FY2024 Labor, Health and Human Services, Education and Related Agencies Appropriations bill (H.R.5894/S.2624. Advocate for Defense Health Research Programs (CDMRP) in the FY24 Defense Appropriations Act, specifically the Melanoma Research Program (MRP) (H.R.4635/S.2587). Support H.R.3503,NIH Clinical Trial Diversity Act.
H.R. 1940, the Tanning Tax Repeal Act of 2025; H.R. 1, the One Big Beautiful Bill Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Advocate for medical research and prevention funding for the National Institutes of Health and Centers for Disease Control and Prevention via the FY2024 Labor, Health and Human Services, Education and Related Agencies Appropriations bill (H.R.5894/S.2624. Advocate for Defense Health Research Programs (CDMRP) in the FY24 Defense Appropriations Act, specifically the Melanoma Research Program (MRP) (H.R.4635/S.2587). Support H.R.3503,NIH Clinical Trial Diversity Act.
Advocate for adequate and accurate network coverage for dermatologic care within Medicare Advantage. Advocate for increased funding and reforms to Graduate Medical Education. Advocate for improvements to Health Information Technology implementation. Advocate for expansion of telemedicine services under Medicare and increased reimbursement for such services. Advocate for improving disease management and care coordination for patients with chronic diseases. Advocate for relief from Medicare regulations under Medicare Access and CHIP Reauthorization Act (MACRA P.L. 114-110), including the Quality Payment Program (QPP) and specifically the development of advanced alternative payment models (APMs) and implementation of the Merit-Based Incentive Payment System (MIPS). Advocate for Congress to urge CMS to strengthen Qualified Clinical Data Registries (QCDRs) by removing barriers that restrict access to data from EHRs. Advocate for congressional action to hold health care professionals harmless from any cuts related to CMS Evaluation and Management Code proposals in any forthcoming legislative package. Advocate to replace scheduled and anticipated cuts in Medicare payments with positive, inflationary-based updates, eliminate the anticipated conversion factor cut in the CMS proposed rule for the 2024 Medicare Physician Fee Schedule (MPFS) associated with budget neutrality adjustments tied to Evaluation & Management (E/M) Code MPFS policy changes. Support H.R.2474, Strengthening Medicare for Patients and Providers Act. Support H.R. 3674, the Providing Relief and Stability for Medicare Patients Act of 2023. Support the Resident Physician Shortage Reduction Act (S. 1302/H.R. 2389). Advocate regarding matters related to Merit-based Incentive Payment System (MIPS), MIPS Value Pathways (MVPs), and Qualified Clinical Data Registries. H.R. 5213, the Reducing Medically Unnecessary Delays in Care Act of 2023. H.R. 6445/S.2377, the Medicare Audiology Access Improvement Act of 2023. H.R. 6487/S.3805, the No Fees for EFTs Act. H.R. 6545, the Physician Fee Schedule Update and Improvements Act. H.R. 6683, the Preserving Seniors' Access to Physicians Act of 2023; Draft legislation, To amend title XVIII of the Social Security Act to transform the Merit-based Incentive Payment System into the Data-Driven Performance Payment System under the Medicare physician fee schedule, and for other purposes; H.R. 8702/S. 4532, the Improving Seniors Timely Access to Care Act; S. 3503/H.R. 5013, Value in Health Care Act; S. 4935, Physician Fee Stability Act; S. 2477/H.R. 1770, Equitable Community Access to Pharmacist Services Act; H.R. 10073, the Medicare Patient Access and Practice Stabilization Act of 2024; H.R. 10545, the American Relief Act, 2025
Lobby members of Congress regarding issues related to telemedicine. Advocate for a stable supply of medications and for mitigation of drug shortages, including lidocaine. Advocate for increased transparency regarding drug pricing. Advocate for reducing barriers to entry of generic drugs into the marketplace. Advocate for transparency on the part of pharmaceutical benefit managers. Advocate for patient access to compounded medications. Advocate for reducing the burdens of utilization management tools, including step therapy and prior authorization for pharmaceuticals and services. Advocate for a stable supply of medications and mitigate drug shortages. Lobby members of the House to join the Congressional Skin Cancer Caucus. Advocate for adequate and accurate network coverage for dermatologic care within health insurance exchange networks. Support H.R. 2630/S. 652, Safe Step Act. Advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans. Advocate for the continued and increased funding of Community Health Centers. Advocate for implementation of surprise medical billing legislation (enacted as part of P.L. 116-260, Consolidated Appropriations Act, 2021, H.R. 133) as intended by Congress. Support H.R. 5894/S. 2624. Support H.R. 1202/S. 704, Resident Education Deferred Interest Act or the REDI Act Support H.R. 2389/S1032, the Resident Physician Shortage Reduction Act Lobbied Congress on physician workforce, administrative burden, and workforce diversity issues Advocate for the FDA to implement the 2015 rule, General and Plastic Surgery Devices: Restricted Sale, Distribution, and Use of Sunlamp Products; and the Sunlamp Products Proposed; Amendment to Performance Standard, which would ban minors under the age of 18 from using tanning beds. Advocate for implementation of language to direct the Secretary of Health and Human Services to open a public docket for the submission of public comments regarding factors that should be taken into consideration when reviewing a proposed modification to an approved risk evaluation and mitigation strategy, and for other purposes (enacted as part of P.L. 117-328, Consolidated Appropriations Act, 2023, H.R. 2617). Advocate to replace scheduled and anticipated cuts in Medicare payments with positive, inflationary-based updates, eliminate the anticipated conversion factor cut in the CMS proposed rule for the 2024 Medicare Physician Fee Schedule (MPFS) associated with budget neutrality adjustments tied to Evaluation & Management (E/M) Code MPFS policy changes Advocate against H.R 618, Improving Access to Workers Compensation for Injured Federal Workers Act, which expands the role of nurse practitioners and physician assistants in providing services to injured federal workers under the federal workers' compensation program. Lobbied Congress on impact of the burden of small business issues impacting small physician practices, including Medicare reimbursement cuts. Advocate for H. Res. 365, in support of efforts to curb the incidences of skin cancer beginning with childhood skin protection. Support H.R.2474, Strengthening Medicare for Patients and Providers Act. Support H.R. 2761, S. 705, Specialty Physicians Advancing Rural Care Act (SPARC Act). Support H.R. 4402, Protecting and Continuing Physician Education and Patient Care Act Support H.R. 830/S. 1375, the Help Ensure Lower Patient (HELP) Copays Act. Support H.R. 3674, the Providing Relief and Stability for Medicare Patients Act of 2023. Support S. 935, the Fair Accountability & Innovative Research (FAIR) Drug Pricing Act. Support H.R. 4968, Getting Over Lengthy Delays in Care as Required by Doctors (GOLD CARD) Act. Support H.R.2389/S.1302, the Resident Physicians Shortage Reduction Act. Advocate regarding matters related to Merit-based Incentive Payment System (MIPS), MIPS Value Pathways (MVPs), and Qualified Clinical Data Registries. Advocate regarding AADA efforts in skin cancer prevention and AADA skin cancer prevention programs and initiatives. H.R.7153/S.3679, the Dr. Lorna Breen Health Care Provider Protection Reauthorization Act. S.Res.567/H.Res.1089, a resolution recognizing the seriousness of widespread health care worker burnout in the United States and the need to strengthen health workforce well-being, and expressing support for the designation of March 18, 2024, as the inaugural "Health Workforce Well-Being Day of Awareness".; H.R. 2819, Good Samaritan Health Professionals Act; S. 4349, Electronic Prior Authorization for Prescription Drugs Act
Lobby members of Congress to implement oversight of the FDA regarding the importance of sunscreen use during the proposed rule to put into effect a final monograph for nonprescription, over-the-counter (OTC) sunscreen drug products. Advocate for a stable supply of medications and mitigate drug shortages. Advocate for increased transparency regarding drug pricing. Advocate for reducing barriers to entry of generic drugs into the marketplace. Advocate for transparency on the part of pharmaceutical benefit managers. Advocate for patient access to compounded medications. Advocate for reducing the burdens of utilization management tools, including step therapy and prior authorization for pharmaceuticals. Advocate for implementation of language to direct the Secretary of Health and Human Services to open a public docket for the submission of public comments regarding factors that should be taken into consideration when reviewing a proposed modification to an approved risk evaluation and mitigation strategy, and for other purposes (enacted as part of P.L. 117-328, Consolidated Appropriations Act, 2023, H.R. 2617). Support S. 127, Pharmacy Benefit Manager Transparency Act Support H.R. 830/ S. 1375, the Help Ensure Lower Patient (HELP) Copays Act. Support S. 935, the Fair Accountability & Innovative Research (FAIR) Drug Pricing Act Support H.R. 2630/S. 652, Safe Step Act. Support H.R. 167, Patient Access to Urgent-Use Pharmacy Compounding Act
Oppose H.R.936/S.1937, Tanning Tax Repeal Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Science & Technology Policy (OSTP), SENATE, White House Office
Advocate for adequate and accurate network coverage for dermatologic care within Medicare Advantage. Advocate for increased funding and reforms to Graduate Medical Education. Advocate for improvements to Health Information Technology implementation. Advocate for expansion of telemedicine services under Medicare and increased reimbursement for such services. Advocate for improving disease management and care coordination for patients with chronic diseases. Advocate for relief from Medicare regulations under Medicare Access and CHIP Reauthorization Act (MACRA P.L. 114-110), including the Quality Payment Program (QPP) and specifically the development of advanced alternative payment models (APMs) and implementation of the Merit-Based Incentive Payment System (MIPS). Advocate for Congress to urge CMS to strengthen Qualified Clinical Data Registries (QCDRs) by removing barriers that restrict access to data from EHRs. Advocate for congressional action to hold health care professionals harmless from any cuts related to CMS Evaluation and Management Code proposals in any forthcoming legislative package. Advocate to replace scheduled and anticipated cuts in Medicare payments with positive, inflationary-based updates, eliminate the anticipated conversion factor cut in the CMS proposed rule for the 2024 Medicare Physician Fee Schedule (MPFS) associated with budget neutrality adjustments tied to Evaluation & Management (E/M) Code MPFS policy changes. Support H.R.2474, Strengthening Medicare for Patients and Providers Act. Support H.R. 3674, the Providing Relief and Stability for Medicare Patients Act of 2023. Support the Resident Physician Shortage Reduction Act (S. 1302/H.R. 2389). Advocate regarding matters related to Merit-based Incentive Payment System (MIPS), MIPS Value Pathways (MVPs), and Qualified Clinical Data Registries. H.R. 5213, the Reducing Medically Unnecessary Delays in Care Act of 2023. H.R. 6445/S.2377, the Medicare Audiology Access Improvement Act of 2023. H.R. 6487/S.3805, the No Fees for EFTs Act. H.R. 6545, the Physician Fee Schedule Update and Improvements Act. H.R. 6683, the Preserving Seniors' Access to Physicians Act of 2023; Draft legislation, To amend title XVIII of the Social Security Act to transform the Merit-based Incentive Payment System into the Data-Driven Performance Payment System under the Medicare physician fee schedule, and for other purposes; H.R. 8702/S. 4532, the Improving Seniors Timely Access to Care Act; S. 3503/H.R. 5013, Value in Health Care Act; S. 4935, Physician Fee Stability Act; S. 2477/H.R. 1770, Equitable Community Access to Pharmacist Services Act
Oppose H.R.936/S.1937, Tanning Tax Repeal Act
Advocate for medical research and prevention funding for the National Institutes of Health and Centers for Disease Control and Prevention via the FY2024 Labor, Health and Human Services, Education and Related Agencies Appropriations bill (H.R.5894/S.2624). Advocate for adequate funding for the Agency for Healthcare Research and Quality (AHRQ) via the FY2024 Labor, Health and Human Services, Education and Related Agencies Appropriations bill (H.R.5894/S.2624). Advocate for the FDA to implement the 2015 rule, General and Plastic Surgery Devices: Restricted Sale, Distribution, and Use of Sunlamp Products; and the Sunlamp Products Proposed; Amendment to Performance Standard, which would ban minors under the age of 18 from using tanning beds. Advocate to replace scheduled and anticipated cuts in Medicare payments with positive, inflationary-based updates, eliminate the anticipated conversion factor cut in the CMS proposed rule for the 2024 Medicare Physician Fee Schedule (MPFS) associated with budget neutrality adjustments tied to Evaluation & Management (E/M) Code MPFS policy changes. Advocate for increased funding for the Indian Health Services via the FY 2024 Interior-Environment Appropriations bill (H.R.4821/S.2605). Advocate for Defense Health Research Programs (CDMRP) in the FY24 Defense Appropriations Act, specifically the Melanoma Research Program (MRP) (H.R. 4365/S.2587). Advocate for report language studying veterans access to dermatologic care and preventative measures via the FY2024 Veterans Affairs-Military-Construction Appropriations bill (H.R. 4366/S.2127) H.R.4366, the Consolidated Appropriations Act, 2024
Lobby members of Congress to implement oversight of the FDA regarding the importance of sunscreen use during the proposed rule to put into effect a final monograph for nonprescription, over-the-counter (OTC) sunscreen drug products. Advocate for a stable supply of medications and mitigate drug shortages. Advocate for increased transparency regarding drug pricing. Advocate for reducing barriers to entry of generic drugs into the marketplace. Advocate for transparency on the part of pharmaceutical benefit managers. Advocate for patient access to compounded medications. Advocate for reducing the burdens of utilization management tools, including step therapy and prior authorization for pharmaceuticals. Advocate for implementation of language to direct the Secretary of Health and Human Services to open a public docket for the submission of public comments regarding factors that should be taken into consideration when reviewing a proposed modification to an approved risk evaluation and mitigation strategy, and for other purposes (enacted as part of P.L. 117-328, Consolidated Appropriations Act, 2023, H.R. 2617). Support S. 127, Pharmacy Benefit Manager Transparency Act Support H.R. 830/ S. 1375, the Help Ensure Lower Patient (HELP) Copays Act. Support S. 935, the Fair Accountability & Innovative Research (FAIR) Drug Pricing Act Support H.R. 2630/S. 652, Safe Step Act. Support H.R. 167, Patient Access to Urgent-Use Pharmacy Compounding Act
Advocate for medical research and prevention funding for the National Institutes of Health and Centers for Disease Control and Prevention via the FY2024 Labor, Health and Human Services, Education and Related Agencies Appropriations bill (H.R.5894/S.2624. Advocate for Defense Health Research Programs (CDMRP) in the FY24 Defense Appropriations Act, specifically the Melanoma Research Program (MRP) (H.R.4635/S.2587). Support H.R.3503,NIH Clinical Trial Diversity Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Science & Technology Policy (OSTP), SENATE, White House Office
Oppose H.R.936/S.1937, Tanning Tax Repeal Act
Lobby members of Congress to implement oversight of the FDA regarding the importance of sunscreen use during the proposed rule to put into effect a final monograph for nonprescription, over-the-counter (OTC) sunscreen drug products. Advocate for a stable supply of medications and mitigate drug shortages. Advocate for increased transparency regarding drug pricing. Advocate for reducing barriers to entry of generic drugs into the marketplace. Advocate for transparency on the part of pharmaceutical benefit managers. Advocate for patient access to compounded medications. Advocate for reducing the burdens of utilization management tools, including step therapy and prior authorization for pharmaceuticals. Advocate for implementation of language to direct the Secretary of Health and Human Services to open a public docket for the submission of public comments regarding factors that should be taken into consideration when reviewing a proposed modification to an approved risk evaluation and mitigation strategy, and for other purposes (enacted as part of P.L. 117-328, Consolidated Appropriations Act, 2023, H.R. 2617). Support S. 127, Pharmacy Benefit Manager Transparency Act Support H.R. 830/ S. 1375, the Help Ensure Lower Patient (HELP) Copays Act. Support S. 935, the Fair Accountability & Innovative Research (FAIR) Drug Pricing Act Support H.R. 2630/S. 652, Safe Step Act. Support H.R. 167, Patient Access to Urgent-Use Pharmacy Compounding Act
Advocate for medical research and prevention funding for the National Institutes of Health and Centers for Disease Control and Prevention via the FY2024 Labor, Health and Human Services, Education and Related Agencies Appropriations bill (H.R.5894/S.2624). Advocate for adequate funding for the Agency for Healthcare Research and Quality (AHRQ) via the FY2024 Labor, Health and Human Services, Education and Related Agencies Appropriations bill (H.R.5894/S.2624). Advocate for the FDA to implement the 2015 rule, General and Plastic Surgery Devices: Restricted Sale, Distribution, and Use of Sunlamp Products; and the Sunlamp Products Proposed; Amendment to Performance Standard, which would ban minors under the age of 18 from using tanning beds. Advocate to replace scheduled and anticipated cuts in Medicare payments with positive, inflationary-based updates, eliminate the anticipated conversion factor cut in the CMS proposed rule for the 2024 Medicare Physician Fee Schedule (MPFS) associated with budget neutrality adjustments tied to Evaluation & Management (E/M) Code MPFS policy changes. Advocate for increased funding for the Indian Health Services via the FY 2024 Interior-Environment Appropriations bill (H.R.4821/S.2605). Advocate for Defense Health Research Programs (CDMRP) in the FY24 Defense Appropriations Act, specifically the Melanoma Research Program (MRP) (H.R. 4365/S.2587). Advocate for report language studying veterans access to dermatologic care and preventative measures via the FY2024 Veterans Affairs-Military-Construction Appropriations bill (H.R. 4366/S.2127) H.R.4366, the Consolidated Appropriations Act, 2024
Advocate for medical research and prevention funding for the National Institutes of Health and Centers for Disease Control and Prevention via the FY2024 Labor, Health and Human Services, Education and Related Agencies Appropriations bill (H.R.5894/S.2624. Advocate for Defense Health Research Programs (CDMRP) in the FY24 Defense Appropriations Act, specifically the Melanoma Research Program (MRP) (H.R.4635/S.2587). Support H.R.3503,NIH Clinical Trial Diversity Act.
Advocate for adequate and accurate network coverage for dermatologic care within Medicare Advantage. Advocate for increased funding and reforms to Graduate Medical Education. Advocate for improvements to Health Information Technology implementation. Advocate for expansion of telemedicine services under Medicare and increased reimbursement for such services. Advocate for improving disease management and care coordination for patients with chronic diseases. Advocate for relief from Medicare regulations under Medicare Access and CHIP Reauthorization Act (MACRA P.L. 114-110), including the Quality Payment Program (QPP) and specifically the development of advanced alternative payment models (APMs) and implementation of the Merit-Based Incentive Payment System (MIPS). Advocate for Congress to urge CMS to strengthen Qualified Clinical Data Registries (QCDRs) by removing barriers that restrict access to data from EHRs. Advocate for congressional action to hold health care professionals harmless from any cuts related to CMS Evaluation and Management Code proposals in any forthcoming legislative package. Advocate to replace scheduled and anticipated cuts in Medicare payments with positive, inflationary-based updates, eliminate the anticipated conversion factor cut in the CMS proposed rule for the 2024 Medicare Physician Fee Schedule (MPFS) associated with budget neutrality adjustments tied to Evaluation & Management (E/M) Code MPFS policy changes. Support H.R.2474, Strengthening Medicare for Patients and Providers Act. Support H.R. 3674, the Providing Relief and Stability for Medicare Patients Act of 2023. Support the Resident Physician Shortage Reduction Act (S. 1302/H.R. 2389). Advocate regarding matters related to Merit-based Incentive Payment System (MIPS), MIPS Value Pathways (MVPs), and Qualified Clinical Data Registries. H.R. 5213, the Reducing Medically Unnecessary Delays in Care Act of 2023. H.R. 6445/S.2377, the Medicare Audiology Access Improvement Act of 2023. H.R. 6487/S.3805, the No Fees for EFTs Act. H.R. 6545, the Physician Fee Schedule Update and Improvements Act. H.R. 6683, the Preserving Seniors' Access to Physicians Act of 2023; Draft legislation, To amend title XVIII of the Social Security Act to transform the Merit-based Incentive Payment System into the Data-Driven Performance Payment System under the Medicare physician fee schedule, and for other purposes; H.R. 8702/S. 4532, the Improving Seniors Timely Access to Care Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Science & Technology Policy (OSTP), SENATE, White House Office
Lobby members of Congress regarding issues related to telemedicine. Advocate for a stable supply of medications and for mitigation of drug shortages, including lidocaine. Advocate for increased transparency regarding drug pricing. Advocate for reducing barriers to entry of generic drugs into the marketplace. Advocate for transparency on the part of pharmaceutical benefit managers. Advocate for patient access to compounded medications. Advocate for reducing the burdens of utilization management tools, including step therapy and prior authorization for pharmaceuticals and services. Advocate for a stable supply of medications and mitigate drug shortages. Lobby members of the House to join the Congressional Skin Cancer Caucus. Advocate for adequate and accurate network coverage for dermatologic care within health insurance exchange networks. Support H.R. 2630/S. 652, Safe Step Act. Advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans. Advocate for the continued and increased funding of Community Health Centers. Advocate for implementation of surprise medical billing legislation (enacted as part of P.L. 116-260, Consolidated Appropriations Act, 2021, H.R. 133) as intended by Congress. Support H.R. 5894/S. 2624. Support H.R. 1202/S. 704, Resident Education Deferred Interest Act or the REDI Act Support H.R. 2389/S1032, the Resident Physician Shortage Reduction Act Lobbied Congress on physician workforce, administrative burden, and workforce diversity issues Advocate for the FDA to implement the 2015 rule, General and Plastic Surgery Devices: Restricted Sale, Distribution, and Use of Sunlamp Products; and the Sunlamp Products Proposed; Amendment to Performance Standard, which would ban minors under the age of 18 from using tanning beds. Advocate for implementation of language to direct the Secretary of Health and Human Services to open a public docket for the submission of public comments regarding factors that should be taken into consideration when reviewing a proposed modification to an approved risk evaluation and mitigation strategy, and for other purposes (enacted as part of P.L. 117-328, Consolidated Appropriations Act, 2023, H.R. 2617). Advocate to replace scheduled and anticipated cuts in Medicare payments with positive, inflationary-based updates, eliminate the anticipated conversion factor cut in the CMS proposed rule for the 2024 Medicare Physician Fee Schedule (MPFS) associated with budget neutrality adjustments tied to Evaluation & Management (E/M) Code MPFS policy changes Advocate against H.R 618, Improving Access to Workers Compensation for Injured Federal Workers Act, which expands the role of nurse practitioners and physician assistants in providing services to injured federal workers under the federal workers' compensation program. Lobbied Congress on impact of the burden of small business issues impacting small physician practices, including Medicare reimbursement cuts. Advocate for H. Res. 365, in support of efforts to curb the incidences of skin cancer beginning with childhood skin protection. Support H.R.2474, Strengthening Medicare for Patients and Providers Act. Support H.R. 2761, S. 705, Specialty Physicians Advancing Rural Care Act (SPARC Act). Support H.R. 4402, Protecting and Continuing Physician Education and Patient Care Act Support H.R. 830/S. 1375, the Help Ensure Lower Patient (HELP) Copays Act. Support H.R. 3674, the Providing Relief and Stability for Medicare Patients Act of 2023. Support S. 935, the Fair Accountability & Innovative Research (FAIR) Drug Pricing Act. Support H.R. 4968, Getting Over Lengthy Delays in Care as Required by Doctors (GOLD CARD) Act. Support H.R.2389/S.1302, the Resident Physicians Shortage Reduction Act. Advocate regarding matters related to Merit-based Incentive Payment System (MIPS), MIPS Value Pathways (MVPs), and Qualified Clinical Data Registries. Advocate regarding AADA efforts in skin cancer prevention and AADA skin cancer prevention programs and initiatives. H.R.7153/S.3679, the Dr. Lorna Breen Health Care Provider Protection Reauthorization Act. S.Res.567/H.Res.1089, a resolution recognizing the seriousness of widespread health care worker burnout in the United States and the need to strengthen health workforce well-being, and expressing support for the designation of March 18, 2024, as the inaugural "Health Workforce Well-Being Day of Awareness".
Advocate for adequate and accurate network coverage for dermatologic care within Medicare Advantage. Advocate for increased funding and reforms to Graduate Medical Education. Advocate for improvements to Health Information Technology implementation. Advocate for expansion of telemedicine services under Medicare and increased reimbursement for such services. Advocate for improving disease management and care coordination for patients with chronic diseases. Advocate for relief from Medicare regulations under Medicare Access and CHIP Reauthorization Act (MACRA P.L. 114-110), including the Quality Payment Program (QPP) and specifically the development of advanced alternative payment models (APMs) and implementation of the Merit-Based Incentive Payment System (MIPS). Advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans. Advocate for Congress to urge CMS to strengthen Qualified Clinical Data Registries (QCDRs) by removing barriers that restrict access to data from EHRs. Advocate for congressional action to hold health care professionals harmless from any cuts related to CMS Evaluation and Management Code proposals in any forthcoming legislative package. Advocate to replace scheduled and anticipated cuts in Medicare payments with positive, inflationary-based updates, eliminate the anticipated conversion factor cut in the CMS proposed rule for the 2024 Medicare Physician Fee Schedule (MPFS) associated with budget neutrality adjustments tied to Evaluation & Management (E/M) Code MPFS policy changes. Support H.R.2474, Strengthening Medicare for Patients and Providers Act. Support H.R. 3674, the Providing Relief and Stability for Medicare Patients Act of 2023. Support the Resident Physician Shortage Reduction Act (S. 1302/H.R. 2389). Advocate regarding matters related to Merit-based Incentive Payment System (MIPS), MIPS Value Pathways (MVPs), and Qualified Clinical Data Registries. H.R. 5213, the Reducing Medically Unnecessary Delays in Care Act of 2023. H.R. 6445/S.2377, the Medicare Audiology Access Improvement Act of 2023. H.R. 6487/S.3805, the No Fees for EFTs Act. H.R. 6545, the Physician Fee Schedule Update and Improvements Act. H.R. 6683, the Preserving Seniors' Access to Physicians Act of 2023;
Lobby members of Congress to implement oversight of the FDA regarding the importance of sunscreen use during the proposed rule to put into effect a final monograph for nonprescription, over-the-counter (OTC) sunscreen drug products. Advocate for a stable supply of medications and mitigate drug shortages. Advocate for increased transparency regarding drug pricing. Advocate for reducing barriers to entry of generic drugs into the marketplace. Advocate for transparency on the part of pharmaceutical benefit managers. Advocate for patient access to compounded medications. Advocate for reducing the burdens of utilization management tools, including step therapy and prior authorization for pharmaceuticals. Advocate for implementation of language to direct the Secretary of Health and Human Services to open a public docket for the submission of public comments regarding factors that should be taken into consideration when reviewing a proposed modification to an approved risk evaluation and mitigation strategy, and for other purposes (enacted as part of P.L. 117-328, Consolidated Appropriations Act, 2023, H.R. 2617). Support S. 127, Pharmacy Benefit Manager Transparency Act Support H.R. 830/ S. 1375, the Help Ensure Lower Patient (HELP) Copays Act. Support S. 935, the Fair Accountability & Innovative Research (FAIR) Drug Pricing Act Support H.R. 2630/S. 652, Safe Step Act. Support H.R. 167, Patient Access to Urgent-Use Pharmacy Compounding Act
Advocate for medical research and prevention funding for the National Institutes of Health and Centers for Disease Control and Prevention via the FY2024 Labor, Health and Human Services, Education and Related Agencies Appropriations bill (H.R.5894/S.2624). Advocate for adequate funding for the Agency for Healthcare Research and Quality (AHRQ) via the FY2024 Labor, Health and Human Services, Education and Related Agencies Appropriations bill (H.R.5894/S.2624). Advocate for the FDA to implement the 2015 rule, General and Plastic Surgery Devices: Restricted Sale, Distribution, and Use of Sunlamp Products; and the Sunlamp Products Proposed; Amendment to Performance Standard, which would ban minors under the age of 18 from using tanning beds. Advocate to replace scheduled and anticipated cuts in Medicare payments with positive, inflationary-based updates, eliminate the anticipated conversion factor cut in the CMS proposed rule for the 2024 Medicare Physician Fee Schedule (MPFS) associated with budget neutrality adjustments tied to Evaluation & Management (E/M) Code MPFS policy changes. Advocate for increased funding for the Indian Health Services via the FY 2024 Interior-Environment Appropriations bill (H.R.4281/S.2605). Advocate for Defense Health Research Programs (CDMRP) in the FY24 Defense Appropriations Act, specifically the Melanoma Research Program (MRP) (H.R. 4365/S.2587). Advocate for report language studying veterans access to dermatologic care and preventative measures via the FY2024 Veterans Affairs-Military-Construction Appropriations bill (H.R. 4366/S.2127) H.R.4366, the Consolidated Appropriations Act, 2024
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Science & Technology Policy (OSTP), SENATE, White House Office